<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genes (Basel)</journal-id>
<journal-id journal-id-type="iso-abbrev">Genes (Basel)</journal-id>
<journal-id journal-id-type="publisher-id">genes</journal-id>
<journal-title-group>
<journal-title>Genes</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4425</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31861090</article-id>
<article-id pub-id-type="pmc">6947179</article-id>
<article-id pub-id-type="doi">10.3390/genes10121050</article-id>
<article-id pub-id-type="publisher-id">genes-10-01050</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Spectrum of <italic>PAX6</italic> Mutations and Genotype-Phenotype Correlations in the Eye</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lima Cunha</surname>
<given-names>Dulce</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-10-01050">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arno</surname>
<given-names>Gavin</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-10-01050">1</xref>
<xref ref-type="aff" rid="af2-genes-10-01050">2</xref>
<xref ref-type="aff" rid="af3-genes-10-01050">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0087-1626</contrib-id>
<name>
<surname>Corton</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="af4-genes-10-01050">4</xref>
<xref ref-type="aff" rid="af5-genes-10-01050">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1688-5360</contrib-id>
<name>
<surname>Moosajee</surname>
<given-names>Mariya</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-10-01050">1</xref>
<xref ref-type="aff" rid="af2-genes-10-01050">2</xref>
<xref ref-type="aff" rid="af3-genes-10-01050">3</xref>
<xref ref-type="corresp" rid="c1-genes-10-01050">*</xref>
</contrib>
</contrib-group>
<aff id="af1-genes-10-01050"><label>1</label>Institute of Ophthalmology, UCL, London EC1V 9EL, UK</aff>
<aff id="af2-genes-10-01050"><label>2</label>Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK</aff>
<aff id="af3-genes-10-01050"><label>3</label>Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK</aff>
<aff id="af4-genes-10-01050"><label>4</label>Department of Genetics &amp; Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital—Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain</aff>
<aff id="af5-genes-10-01050"><label>5</label>Centre for Biomedical Network Research on Rare Diseases (CIBERER), 28029 Madrid, Spain</aff>
<author-notes>
<corresp id="c1-genes-10-01050"><label>*</label>Correspondence: <email>m.moosajee@ucl.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>12</issue>
<elocation-id>1050</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The transcription factor PAX6 is essential in ocular development in vertebrates, being considered the master regulator of the eye. During eye development, it is essential for the correct patterning and formation of the multi-layered optic cup and it is involved in the developing lens and corneal epithelium. In adulthood, it is mostly expressed in cornea, iris, and lens. <italic>PAX6</italic> is a dosage-sensitive gene and it is highly regulated by several elements located upstream, downstream, and within the gene. There are more than 500 different mutations described to affect <italic>PAX6</italic> and its regulatory regions, the majority of which lead to <italic>PAX6</italic> haploinsufficiency, causing several ocular and systemic abnormalities. Aniridia is an autosomal dominant disorder that is marked by the complete or partial absence of the iris, foveal hypoplasia, and nystagmus, and is caused by heterozygous <italic>PAX6</italic> mutations. Other ocular abnormalities have also been associated with <italic>PAX6</italic> changes, and genotype-phenotype correlations are emerging. This review will cover recent advancements in <italic>PAX6</italic> regulation, particularly the role of several enhancers that are known to regulate <italic>PAX6</italic> during eye development and disease. We will also present an updated overview of the mutation spectrum, where an increasing number of mutations in the non-coding regions have been reported. Novel genotype-phenotype correlations will also be discussed.</p>
</abstract>
<kwd-group>
<kwd>aniridia</kwd>
<kwd>enhancers</kwd>
<kwd>genotype-phenotype correlations</kwd>
<kwd>haploinsufficiency</kwd>
<kwd>
<italic>PAX6</italic>
</kwd>
<kwd>paired domain</kwd>
<kwd>microphthalmia</kwd>
<kwd>non-coding variants</kwd>
<kwd>premature termination codon</kwd>
<kwd>regulatory regions</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-genes-10-01050" sec-type="intro">
<title>1. Introduction</title>
<p>The human paired box 6, as coded by the <italic>PAX6</italic> gene, is a member of the PAX family of transcription factors, which are evolutionarily highly conserved among metazoans and are characterized by the presence of a conserved DNA-binding domain, the paired domain [<xref ref-type="bibr" rid="B1-genes-10-01050">1</xref>]. Positional cloning identified it in the early 1990s [<xref ref-type="bibr" rid="B2-genes-10-01050">2</xref>]. At the same time, murine <italic>Pax6</italic> was also identified by the screening of mouse embryonic expression libraries [<xref ref-type="bibr" rid="B3-genes-10-01050">3</xref>] and associated as the causal gene of an heterozygous <italic>Sey</italic> mouse strain (<italic>Sey</italic><sup>+/−</sup>) [<xref ref-type="bibr" rid="B4-genes-10-01050">4</xref>], which presented with microphthalmia, iris hypoplasia, cataracts, and corneal opacifications, resembling human developmental eye disorder aniridia [<xref ref-type="bibr" rid="B5-genes-10-01050">5</xref>]. Further <italic>PAX6</italic> homologous genes were later identified in zebrafish (<italic>pax6a</italic> and <italic>pax6b</italic>) [<xref ref-type="bibr" rid="B6-genes-10-01050">6</xref>], quail [<xref ref-type="bibr" rid="B7-genes-10-01050">7</xref>], and <italic>Drosophila</italic> (<italic>ey, toy, eyg,</italic> and <italic>toe</italic>) [<xref ref-type="bibr" rid="B8-genes-10-01050">8</xref>]. </p>
<p>PAX6 is considered to be the master regulator of the eye, since the overexpression of the gene resulted in ectopic eye formation in both <italic>Drosophila</italic> and <italic>Xenopus</italic> [<xref ref-type="bibr" rid="B9-genes-10-01050">9</xref>,<xref ref-type="bibr" rid="B10-genes-10-01050">10</xref>]. During early eye development, <italic>PAX6</italic> is expressed on the surface and neural ectoderm. By week five in human gestation, it is expressed throughout the optic vesicle, which then invaginates to form the bi-layered optic cup, where PAX6 is found in both neural and pigmented retinal layers [<xref ref-type="bibr" rid="B11-genes-10-01050">11</xref>]. It is also highly expressed in the anterior segment structures that are derived from the surface ectoderm, including the lens vesicle and corneal epithelium [<xref ref-type="bibr" rid="B11-genes-10-01050">11</xref>,<xref ref-type="bibr" rid="B12-genes-10-01050">12</xref>]. Postnatally, <italic>PAX6</italic> is restricted to retinal ganglion, amacrine and horizontal cells, lens, cornea, conjunctiva, iris, and ciliary body [<xref ref-type="bibr" rid="B12-genes-10-01050">12</xref>,<xref ref-type="bibr" rid="B13-genes-10-01050">13</xref>]. Outside the eye, it is expressed in the pancreas, nasal epithelia, and several distinct regions of the central nervous system (CNS), like the forebrain, hindbrain, and spinal cord [<xref ref-type="bibr" rid="B12-genes-10-01050">12</xref>].</p>
<p>Defects in <italic>PAX6</italic> gene can affect eye development and result in a broad range of clinical phenotypes, with the most common being aniridia, a pan ocular disorder that is primarily characterised by the absence or hypoplasia of the iris, nystagmus, and foveal hypoplasia, accompanied by cataracts, glaucoma and corneal keratopathy [<xref ref-type="bibr" rid="B14-genes-10-01050">14</xref>]. Other ocular phenotypes include microphthalmia, optic nerve anomalies, or anterior segment dysgenesis [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>]. Systemic features can include neurodevelopmental abnormalities, like autism and attention deficit hyperactivity (ADHD) disorders, language impairment [<xref ref-type="bibr" rid="B16-genes-10-01050">16</xref>,<xref ref-type="bibr" rid="B17-genes-10-01050">17</xref>,<xref ref-type="bibr" rid="B18-genes-10-01050">18</xref>], and in some cases the absence or malformations of the pineal and pituitary gland [<xref ref-type="bibr" rid="B19-genes-10-01050">19</xref>,<xref ref-type="bibr" rid="B20-genes-10-01050">20</xref>,<xref ref-type="bibr" rid="B21-genes-10-01050">21</xref>,<xref ref-type="bibr" rid="B22-genes-10-01050">22</xref>]. Defects in <italic>PAX6</italic> have also been associated with obesity and diabetes mellitus due to its role in pancreas development [<xref ref-type="bibr" rid="B23-genes-10-01050">23</xref>,<xref ref-type="bibr" rid="B24-genes-10-01050">24</xref>].</p>
<p>The majority of <italic>PAX6</italic> mutations are heterozygous and they result in loss of one allele causing <italic>PAX6</italic> haploinsufficiency. This review will highlight recent advances in <italic>PAX6</italic> function and regulation and will particularly focus on the spectrum of mutations in the eye and resultant genotype-phenotype correlations. </p>
</sec>
<sec id="sec2-genes-10-01050">
<title>2. <italic>PAX6</italic></title>
<p><italic>PAX6</italic> (OMIM 607108) locus was mapped to the chromosome region 11p13, being 22 Kb in size, but with regulatory regions spanning ~450 Kb of genomic DNA [<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>,<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]. The gene contains 14 exons, with the first three being non-coding (<xref ref-type="fig" rid="genes-10-01050-f001">Figure 1</xref>A) [<xref ref-type="bibr" rid="B27-genes-10-01050">27</xref>].</p>
<p><italic>PAX6</italic> encodes a protein whose canonical form is approximately 46 KDa and is formed by 422 amino acids. It has two DNA-binding domains, the paired domain (PD) and the homeodomain (HD), -connected by a linker region (<xref ref-type="fig" rid="genes-10-01050-f001">Figure 1</xref>B). At the C-terminal, immediately downstream of the HD, there is also a proline-serine-threonine-rich transactivation domain (PSTD), which is required for initiating transcription and it modulates DNA binding by the HD [<xref ref-type="bibr" rid="B28-genes-10-01050">28</xref>,<xref ref-type="bibr" rid="B29-genes-10-01050">29</xref>]. The PD is, in turn, comprised of a N-terminal subdomain (NTS or PAI) and a C-terminal subdomain (CTS or RED) (<xref ref-type="fig" rid="genes-10-01050-f001">Figure 1</xref>B) [<xref ref-type="bibr" rid="B30-genes-10-01050">30</xref>]. Both subdomains bind the respective consensus DNA sequences and the two major PAX6 isoforms, canonical PAX6 and PAX6(5a), modulate their activity [<xref ref-type="bibr" rid="B31-genes-10-01050">31</xref>,<xref ref-type="bibr" rid="B32-genes-10-01050">32</xref>]. </p>
<p>PAX6(5a) is formed by the alternative splicing of exon 5a between exons 5 and 6, which results in a slightly larger isoform with 436 amino acids (48 KDa) (<xref ref-type="fig" rid="genes-10-01050-f001">Figure 1</xref>B). The extra 14 amino acids encoded by exon 5a are inserted in the NTS of the paired domain, blocking its DNA-binding activity, and unmasking DNA-binding activity of the CTS [<xref ref-type="bibr" rid="B31-genes-10-01050">31</xref>,<xref ref-type="bibr" rid="B33-genes-10-01050">33</xref>]. </p>
<p>A third isoform has been reported in quail and mice—Pax6ΔPD—which lacks the complete PD and it is predicted to result in a truncated protein [<xref ref-type="bibr" rid="B34-genes-10-01050">34</xref>,<xref ref-type="bibr" rid="B35-genes-10-01050">35</xref>]. However, Kim and Lauderdale showed that Pax6ΔPD has a distinct function in mammalian eye development than Pax6 and Pax6(5a), since the overexpression of <italic>Pax6</italic><italic>ΔPD</italic>, while using BAC and YAC transgene systems, lead to severe microphthalmia in both wildtype and Pax6-deficient mice [<xref ref-type="bibr" rid="B36-genes-10-01050">36</xref>,<xref ref-type="bibr" rid="B37-genes-10-01050">37</xref>]. Dual reporter systems during mouse embryonic development showed that Pax6ΔPD isoform, although at lower levels than PD-containing isoforms, was mostly detected in the peripheral neural retina and developing ciliary body, but it was absent from developing lens and cornea [<xref ref-type="bibr" rid="B36-genes-10-01050">36</xref>,<xref ref-type="bibr" rid="B38-genes-10-01050">38</xref>].</p>
<p>The regulation and target genes of each isoform in the eye are not entirely understood. It is hypothesized that canonical PAX6 is more prominent during embryonic development of ocular tissues and is related to differentiation and cell fate determination, while PAX6(5a) seems to be more relevant in the later development or postnatally and for cell proliferation [<xref ref-type="bibr" rid="B39-genes-10-01050">39</xref>,<xref ref-type="bibr" rid="B40-genes-10-01050">40</xref>,<xref ref-type="bibr" rid="B41-genes-10-01050">41</xref>]. Accordingly, expression studies in the mouse lens showed that, during embryonic development, canonical <italic>Pax6</italic> expression is much higher (8:1) when compared to <italic>Pax6(5a).</italic> However, in adult eye tissues (lens, cornea and retina), the ratio changes to 1:1 [<xref ref-type="bibr" rid="B42-genes-10-01050">42</xref>,<xref ref-type="bibr" rid="B43-genes-10-01050">43</xref>]. The same tendency was observed in the retina of chick embryos, where canonical <italic>Pax6</italic> is highly expressed during early stages in the eye primordium and lens placode, whereas <italic>Pax6(5a)</italic> expression gradually increases at later stages, particularly in the cornea and lens [<xref ref-type="bibr" rid="B39-genes-10-01050">39</xref>]. The expression of <italic>Pax6(5a)</italic> actually exceeds canonical <italic>Pax6</italic> expression in the posterior retina of chicks, as birds possess a high density of photoreceptors, comparable to the fovea in primates [<xref ref-type="bibr" rid="B39-genes-10-01050">39</xref>]. These expression studies seem to corroborate human phenotypes, since mutations affecting the CTS, which is the main DNA-binding subdomain of PAX6(5a) isoform, have been associated with isolated foveal hypoplasia (discussed in <xref ref-type="sec" rid="sec6dot3dot1-genes-10-01050">Section 6.3.1</xref>.) [<xref ref-type="bibr" rid="B33-genes-10-01050">33</xref>,<xref ref-type="bibr" rid="B44-genes-10-01050">44</xref>,<xref ref-type="bibr" rid="B45-genes-10-01050">45</xref>]. In the cornea, <italic>PAX6</italic> and <italic>PAX6(5a)</italic> are both expressed in the epithelial layer with a correlation between the expression levels of epithelial-specific keratins and PAX6 isoforms. Overexpression studies showed that canonical PAX6 seems to induce <italic>KRT3</italic>, while PAX6(5a) induced <italic>KRT12</italic> expression via each of their respective PD subdomains [<xref ref-type="bibr" rid="B46-genes-10-01050">46</xref>]. </p>
<p>Although the PAX6 isoforms seem to have independent roles and downstream targets in eye development, the existence of a positive feedback system between Pax6 and Pax6(5a) in mice was also reported [<xref ref-type="bibr" rid="B47-genes-10-01050">47</xref>,<xref ref-type="bibr" rid="B48-genes-10-01050">48</xref>]. Furthermore, the expression ratio between both of the isoforms seems to be essential for normal eye development, and altered ratios has been associated with eye and brain abnormalities [<xref ref-type="bibr" rid="B49-genes-10-01050">49</xref>,<xref ref-type="bibr" rid="B50-genes-10-01050">50</xref>,<xref ref-type="bibr" rid="B51-genes-10-01050">51</xref>]. </p>
</sec>
<sec id="sec3-genes-10-01050">
<title>3. <italic>PAX6</italic> Regulation</title>
<p>Due to the high similarity of mice, <italic>Drosophila</italic>, or quail <italic>Pax6</italic> to human <italic>PAX6</italic>, these organisms have been extensively used as model systems to understand its function and complex regulatory network. Promoters P0 and P1 mainly regulate the transcription of <italic>PAX6</italic> and, to a lesser extent, by internal promoter Pα, giving rise to the many transcripts that encode the different isoforms (<xref ref-type="fig" rid="genes-10-01050-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B52-genes-10-01050">52</xref>,<xref ref-type="bibr" rid="B53-genes-10-01050">53</xref>,<xref ref-type="bibr" rid="B54-genes-10-01050">54</xref>,<xref ref-type="bibr" rid="B55-genes-10-01050">55</xref>]. In situ hybridization experiments in the developing mouse eye showed that P0 promoter initiates gene expression in the cornea and conjunctival epithelia, lens placode, and retina, whereas the P1 promoter mainly initiates transcription in the lens placode, optic vesicle, and CNS, but only weakly in the cornea and conjunctiva. Pα directs the expression in retinal amacrine cells, ciliary body, and iris [<xref ref-type="bibr" rid="B41-genes-10-01050">41</xref>,<xref ref-type="bibr" rid="B52-genes-10-01050">52</xref>,<xref ref-type="bibr" rid="B53-genes-10-01050">53</xref>,<xref ref-type="bibr" rid="B55-genes-10-01050">55</xref>]. </p>
<p>However, tissue- and time-specific regulation of <italic>PAX6</italic> is still largely unknown. Furthermore, there is no direct relationship between the promoters and expression of specific transcripts. In mice, P0 and P1 both initiate the expression of <italic>Pax6</italic> and Pax6<italic>(5a)</italic> transcripts, while Pα-derived transcripts seems to be more directly linked to the Pax6ΔPD isoform [<xref ref-type="bibr" rid="B34-genes-10-01050">34</xref>,<xref ref-type="bibr" rid="B54-genes-10-01050">54</xref>]. These results point to additional regulation elements that act together with promoters in the complex regulation and expression patterns of <italic>PAX6</italic>. Conserved <italic>cis</italic> regulatory regions have been identified both upstream and downstream of <italic>PAX6</italic> and they are summarized in <xref ref-type="table" rid="genes-10-01050-t001">Table 1</xref>. </p>
<p>The ectodermal enhancer (EE) is located ~3.5 Kb upstream of the P0 promoter and regulates the expression of <italic>PAX6</italic> during the development of surface ectodermal-derived tissues (lens, cornea, conjunctiva) [<xref ref-type="bibr" rid="B48-genes-10-01050">48</xref>,<xref ref-type="bibr" rid="B54-genes-10-01050">54</xref>,<xref ref-type="bibr" rid="B60-genes-10-01050">60</xref>,<xref ref-type="bibr" rid="B64-genes-10-01050">64</xref>,<xref ref-type="bibr" rid="B65-genes-10-01050">65</xref>]. In mice, Pax6 was found to directly interact with the EE for autoregulation mechanisms, but it can also interact with Sox2 and Sox3, transcription factors that are also involved in early eye and lens development [<xref ref-type="bibr" rid="B48-genes-10-01050">48</xref>,<xref ref-type="bibr" rid="B66-genes-10-01050">66</xref>]. The Pax6-Sox2 complex can also act on the Sox2 enhancer N-3, showing a synergistic mechanism between these two transcription factors in the regulation of crystallin gene expression [<xref ref-type="bibr" rid="B67-genes-10-01050">67</xref>]. </p>
<p>Approximately 150 Kb downstream of <italic>PAX6</italic>, within introns 7 to 9 of neighbour gene <italic>ELP4</italic>, resides an essential region for <italic>PAX6</italic> regulation—Downstream Regulatory Region (DRR). DRR contains several conserved elements that, if absent, affect <italic>PAX6</italic> expression and normal eye development [<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>,<xref ref-type="bibr" rid="B37-genes-10-01050">37</xref>,<xref ref-type="bibr" rid="B57-genes-10-01050">57</xref>,<xref ref-type="bibr" rid="B58-genes-10-01050">58</xref>]. Although the role of all the elements has not been uncovered, important retinal and iris enhancers are located within this region, since the deletion of DRR in mice completely abolished Pax6 expression in both tissues, as well as in the ciliary body [<xref ref-type="bibr" rid="B37-genes-10-01050">37</xref>]. The deletion of DRR did not dramatically alter Pax6 expression in the lens; the same was observed when the deletion of EE reduced, but did not abolish, Pax6 expression in the lens [<xref ref-type="bibr" rid="B64-genes-10-01050">64</xref>]. These results show that multiple enhancers in multiple regions regulate tissue-specific transcription [<xref ref-type="bibr" rid="B37-genes-10-01050">37</xref>].</p>
<p>Within the DRR, an 800 bp specific enhancer element—SIMO—was found to have a PAX6 PD consensus binding sequence, guiding expression in early and later stages of eye formation, i.e., early surface ectoderm, lens, and neural retinal differentiation, as well as in adulthood, in the lens epithelium, retina, and iris [<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]. SIMO was shown to be critical for <italic>Pax6</italic> expression, as the disruption of this element alone was sufficient for abolishing expression in the developing lens in transgenic mice and zebrafish [<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]. Importantly, deletion or point mutations in SIMO were described to cause aniridia phenotype in humans (discussed in <xref ref-type="sec" rid="sec4dot4-genes-10-01050">Section 4.4</xref>.) [<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>,<xref ref-type="bibr" rid="B68-genes-10-01050">68</xref>]. However, the disruption of <italic>PAX6</italic> expression in the lens when SIMO is affected is most likely due to a self-regulation mechanism of PAX6 itself, which, as in EE, can bind to SIMO via PD and regulate its own expression during eye development in a positive feedback loop [<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]. In the mouse lens, two transcription factors from the TALE homeoproteins family, Meis1 and Meis2, have been identified as upstream regulators of Pax6 by regulating the activity of both EE and SIMO enhancers [<xref ref-type="bibr" rid="B69-genes-10-01050">69</xref>,<xref ref-type="bibr" rid="B70-genes-10-01050">70</xref>]. However, the exact role and regulation mechanisms of these regions on <italic>PAX6</italic> expression in other eye tissues are still largely unknown.</p>
<p>Comparative genomic hybridisation (CGH) analysis of aniridia patients that lacked mutations in <italic>PAX6</italic> coding sequence, pointing to additional regulatory elements located in this region, have identified deletions in <italic>PAX6</italic> 3’ regulatory region (<xref ref-type="fig" rid="genes-10-01050-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B71-genes-10-01050">71</xref>,<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>,<xref ref-type="bibr" rid="B73-genes-10-01050">73</xref>,<xref ref-type="bibr" rid="B74-genes-10-01050">74</xref>,<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>]. As a result, Ansari et al. proposed a critical region for <italic>PAX6</italic> transcriptional activation that spanned approximately 245 Kb and encompassed neighbour genes <italic>DNAJC24</italic>, <italic>IMMP1L</italic>, and <italic>ELP4</italic> [<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>]. More recently, Plaisancie et al. refined it to a 18 Kb region within <italic>ELP4</italic> that does not include SIMO, but another highly conserved enhancer in the DRR, E180B (<xref ref-type="fig" rid="genes-10-01050-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]. These findings highlight a possible role of E180B in aniridia [<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>]. </p>
</sec>
<sec id="sec4-genes-10-01050">
<title>4. <italic>PAX6</italic> Mutation Spectrum</title>
<p>The “<italic>PAX6</italic> Mutation Database” (<uri xlink:href="http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6">http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6</uri>) catalogs all reported mutations in <italic>PAX6</italic> and had, until its last update in 2018, nearly 500 unique variants registered. Intragenic mutations cover ~96% of variants in the database, while the remaining 4% represent the whole gene deletions or variants described in 5’ and 3’ regulatory regions. 80% of intragenic mutations are spread through the complete coding sequence of the gene, but the majority seem to be located within exon 5, 6 and 9, which represent the paired (5 and 6) and homeo- (9) domains of PAX6 protein. While considering the mutation type, the most common intragenic mutations that were observed in <italic>PAX6</italic> are nonsense (39%), followed by frameshifts (27%), missense (12%), splice site (15%), small indels (2%), and C-terminal extension (or run-ons) (2%) (<xref ref-type="fig" rid="genes-10-01050-f003">Figure 3</xref>) [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>,<xref ref-type="bibr" rid="B78-genes-10-01050">78</xref>].</p>
<sec id="sec4dot1-genes-10-01050">
<title>4.1. Premature Termination Codon (PTC) Mutations—Nonsense, Frameshift, and Splice Site Variants</title>
<p>Nucleotide changes that introduce a premature termination codon (PTC) are the most common mutations that are found in <italic>PAX6</italic>. Nonsense, frameshift (out of frame insertions or deletions), and most splice site mutations result in the insertion of a PTC and the consequent termination of translation, accounting for 65–70% of all <italic>PAX6</italic> mutations in the database (<xref ref-type="fig" rid="genes-10-01050-f003">Figure 3</xref>A). Patients with PTC variants tend to present classical aniridia phenotype [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>]. </p>
<p>Although PTC mutations were first thought to cause truncated proteins with a dominant negative effect, it is now accepted that mRNA transcripts containing PTCs located until 50 bp upstream of the last exon junction may be subjected to nonsense-mediated decay (NMD) [<xref ref-type="bibr" rid="B79-genes-10-01050">79</xref>]. Hence, PTCs in <italic>PAX6</italic> mostly result in the degradation of the mutated transcript and the consequent loss of 50% of PAX6 protein levels [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>,<xref ref-type="bibr" rid="B80-genes-10-01050">80</xref>]. Four specific nonsense variants are the most common PTC mutations and they account for more than 20% of all entries in the database: c.607C&gt;T, p.Arg203* (exon 8); c.718C&gt;T, p.Arg240* (exon 9); c.781C&gt;T, p.Arg261* (exon 10); and, c.949C&gt;T, p.Arg317* (exon 11) [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>]. These mutations are located in known methylated CpG islands in exons 8–13, which constitute mutational “hotspots” for aniridia [<xref ref-type="bibr" rid="B78-genes-10-01050">78</xref>]. </p>
<p>Further evidence that NMD is acting on PTC-containing <italic>PAX6</italic> transcripts is the absence of these variants at the 3’ end of the gene [<xref ref-type="bibr" rid="B78-genes-10-01050">78</xref>]. PTCs in this region are expected to escape NMD and they would result in truncated proteins with a possible dominant negative effect and more severe phenotypes [<xref ref-type="bibr" rid="B81-genes-10-01050">81</xref>,<xref ref-type="bibr" rid="B82-genes-10-01050">82</xref>]. However, within the region that was predicted to escape NMD, i.e., the last 50 bp from exon 12 and exon 13, there are no nonsense mutations reported aside from c.1183G&gt;T (p.Gly395*) in the last nucleotide of exon 12, but with predicted mRNA missplicing [<xref ref-type="bibr" rid="B83-genes-10-01050">83</xref>], and all frameshift changes are predicted to cause C-terminal extensions [<xref ref-type="bibr" rid="B78-genes-10-01050">78</xref>].</p>
</sec>
<sec id="sec4dot2-genes-10-01050">
<title>4.2. C-Terminal Exptension (CTE) Variants </title>
<p>Frameshift or point mutations in <italic>PAX6</italic> that alter the stop codon location and allow for translation to continue into the 3’UTR region are less frequent than the variants described earlier, with only 13 entries being reported. Large aniridia cohort studies show that CTEs are associated with aniridia-like phenotypes, with a severity comparable to PTC-causing variants [<xref ref-type="bibr" rid="B84-genes-10-01050">84</xref>,<xref ref-type="bibr" rid="B85-genes-10-01050">85</xref>,<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]. These observations seem to suggest that CTE mutations also generate <italic>PAX6</italic> haploinsufficiency; however, NMD does not degrade these transcripts, since there is no PTC introduced, which means that these changes should indeed produce a longer protein that would most likely be unstable with the affected PST domain transactivation activity. The mechanisms of how CTE mutations cause haploinsufficiency are still unexplained.</p>
</sec>
<sec id="sec4dot3-genes-10-01050">
<title>4.3. Missense Variants</title>
<p>Missense mutations, which cause one amino acid to be replaced by a different one during translation, are reported in ~12% of all entries in the <italic>PAX6</italic> Mutation Database. They are more concentrated in the PD and functional studies predict these variants cause differences in DNA binding and the transactivation activities of PAX6 [<xref ref-type="bibr" rid="B87-genes-10-01050">87</xref>,<xref ref-type="bibr" rid="B88-genes-10-01050">88</xref>,<xref ref-type="bibr" rid="B89-genes-10-01050">89</xref>,<xref ref-type="bibr" rid="B90-genes-10-01050">90</xref>]. These mutations are usually associated with milder, but atypical ocular phenotypes, in some cases without the presence of iris defects [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]. In fact, Tzoulaki et al. reported that missense mutations in <italic>PAX6</italic> are responsible for nearly 70% of non-aniridia eye disorders that were registered in the database (<xref ref-type="fig" rid="genes-10-01050-f003">Figure 3</xref>C) [<xref ref-type="bibr" rid="B78-genes-10-01050">78</xref>], like microphthalmia, optic nerve anomalies, coloboma, isolated foveal hypoplasia, and anterior segment dysgenesis (discussed in <xref ref-type="sec" rid="sec6dot3-genes-10-01050">Section 6.3</xref>.) [<xref ref-type="bibr" rid="B44-genes-10-01050">44</xref>,<xref ref-type="bibr" rid="B90-genes-10-01050">90</xref>,<xref ref-type="bibr" rid="B91-genes-10-01050">91</xref>,<xref ref-type="bibr" rid="B92-genes-10-01050">92</xref>,<xref ref-type="bibr" rid="B93-genes-10-01050">93</xref>].</p>
</sec>
<sec id="sec4dot4-genes-10-01050">
<title>4.4. Non-Coding Variants </title>
<p>An increasing number of reports point to the implication of mutations in non-coding regions in neurodevelopmental and eye disorders [<xref ref-type="bibr" rid="B94-genes-10-01050">94</xref>,<xref ref-type="bibr" rid="B95-genes-10-01050">95</xref>,<xref ref-type="bibr" rid="B96-genes-10-01050">96</xref>]. In the <italic>PAX6</italic> Mutations Database, approximately 15% of all variants are located in the intronic regions and they are generally associated with classical aniridia phenotypes. Although the great majority are located in donor and acceptor sites at the intron-exon borders, deep intronic variants have recently been found in large aniridia patient cohorts [<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>,<xref ref-type="bibr" rid="B83-genes-10-01050">83</xref>]. The deletions or point mutations in non-translated 5’ and 3’UTR of <italic>PAX6</italic> have also been reported [<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>,<xref ref-type="bibr" rid="B97-genes-10-01050">97</xref>,<xref ref-type="bibr" rid="B98-genes-10-01050">98</xref>]. Minigene assays or <italic>in silico</italic> analysis revealed that most of these variants are likely to affect the normal splicing patterns, which results in the formation of PTCs and the consequent <italic>PAX6</italic> haploinsufficiency [<xref ref-type="bibr" rid="B99-genes-10-01050">99</xref>].</p>
<p>Changes in 3’ regulatory <italic>PAX6</italic> regions were also identified in patients presenting with classical aniridia. A single nucleotide change (chr11: 31,685,945G&gt;T) in the SIMO enhancer, ~150Kb downstream of <italic>PAX6</italic>, was described by Bhatia et al., who showed that the phenotype is due to the change affecting a PAX6 recognition site, disrupting its autoregulation loop, and ultimately resulting in decreased <italic>PAX6</italic> expression and haploinsufficiency [<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]. Several deletions that encompass other 3’ regulatory regions have also been reported to cause aniridia (<xref ref-type="fig" rid="genes-10-01050-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B71-genes-10-01050">71</xref>,<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>,<xref ref-type="bibr" rid="B73-genes-10-01050">73</xref>,<xref ref-type="bibr" rid="B74-genes-10-01050">74</xref>,<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>,<xref ref-type="bibr" rid="B76-genes-10-01050">76</xref>,<xref ref-type="bibr" rid="B77-genes-10-01050">77</xref>]. </p>
</sec>
<sec id="sec4dot5-genes-10-01050">
<title>4.5. Chromosomal Rearrangements and Large Deletions </title>
<p>Chromosomal rearrangements (deletions, duplications, translocations, or inversions) involving part or whole <italic>PAX6</italic> gene or regulatory elements account for up to 10% of all aniridia cases. Some reports suggest that the <italic>PAX6</italic> deletions are more frequent in sporadic as compared to familial aniridia patients, while others found no significant difference [<xref ref-type="bibr" rid="B84-genes-10-01050">84</xref>,<xref ref-type="bibr" rid="B100-genes-10-01050">100</xref>,<xref ref-type="bibr" rid="B101-genes-10-01050">101</xref>,<xref ref-type="bibr" rid="B102-genes-10-01050">102</xref>]. Large deletions that encompass <italic>PAX6</italic> and other neighbour genes, such as <italic>WT1</italic>, result in systemic disease, such as WAGR, caracterised by the presence of Wilms tumour, aniridia, genitourinary anomalies, and retardation characterize (described in <xref ref-type="sec" rid="sec6dot2-genes-10-01050">Section 6.2</xref>). </p>
</sec>
<sec id="sec4dot6-genes-10-01050">
<title>4.6. Biallelic Mutations </title>
<p>Mutations that affect both <italic>PAX6</italic> alleles have rarely been described and cause very severe ocular and neurodevelopmental abnormalities, in most cases leading to embryonic death [<xref ref-type="bibr" rid="B103-genes-10-01050">103</xref>,<xref ref-type="bibr" rid="B104-genes-10-01050">104</xref>]. A surviving patient with compound heterozygous mutations in <italic>PAX6</italic> was described as having microphthalmia, neonatal diabetes mellitus, hypopituitarism, and microcephaly, as well as trisomy 21. The patient inherited a missense mutation affecting the PD from the father (c.112C&gt;T, p.Arg38Trp), who had microcornea and severe cataracts, and a nonsense mutation in HD from the mother (c.718C&gt;T, p.Arg240*), who presented with classical familial aniridia [<xref ref-type="bibr" rid="B105-genes-10-01050">105</xref>]. It is plausible to assume that, although affected, the missense variant still contributed for some amount of PAX6 function, since <italic>PAX6</italic> is a very dosage-sensitive gene. Another patient with compound heterozygous nonsense mutations (c.607C&gt;T, p.Arg203* and c.1058C&gt;G, p.Ser353*), presenting with anophthalmia, severe CNS defects, including microcephaly and the complete absence of the corpus callosum and olfactory bulbs, sadly died a few days after birth [<xref ref-type="bibr" rid="B103-genes-10-01050">103</xref>]. </p>
</sec>
</sec>
<sec id="sec5-genes-10-01050">
<title>5. Inheritance of <italic>PAX6</italic> Mutations</title>
<p>Most <italic>PAX6</italic> mutations causing aniridia are heterozygous, sporadic, or familial in an autosomal dominant manner, with significant phenotypic variability. It is estimated that nearly two-thirds of aniridia cases are familial, while the remaining third are considered to be sporadic [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>,<xref ref-type="bibr" rid="B106-genes-10-01050">106</xref>]. Accordingly, sporadic occurrence was described in nearly 40% of entries in the <italic>PAX6</italic> Mutation Database. Up to one-third of sporadic cases of aniridia are associated with <italic>PAX6</italic> and <italic>WT1</italic> deletions, while the remaining two-thirds are considered to be most likely caused by <italic>de novo</italic> point mutations [<xref ref-type="bibr" rid="B89-genes-10-01050">89</xref>]. </p>
<p>Recent studies reported that the rate of mosaicism could be as high as 17.5% among apparent <italic>de novo</italic> cases for different dominant disorders [<xref ref-type="bibr" rid="B83-genes-10-01050">83</xref>,<xref ref-type="bibr" rid="B107-genes-10-01050">107</xref>]. Indeed, several reports have suggested mosaicism as the cause for the variable phenotypes seen in some sporadic <italic>PAX6</italic>-affected patients [<xref ref-type="bibr" rid="B83-genes-10-01050">83</xref>,<xref ref-type="bibr" rid="B93-genes-10-01050">93</xref>,<xref ref-type="bibr" rid="B108-genes-10-01050">108</xref>,<xref ref-type="bibr" rid="B109-genes-10-01050">109</xref>]. A recent study from Tarilonte et al. proved the existence of post-zygotic parental mosaicism in three unrelated Spanish families with variable aniridia or microphthalmia phenotypes caused by heterozygous nonsense (c.771G&gt;A, p.Trp257* and c.120C&gt;A, p.Cys40*) or missense (c.178T&gt;C, p.Tyr60His) <italic>PAX6</italic> mutations, respectively [<xref ref-type="bibr" rid="B110-genes-10-01050">110</xref>]. Quantitative analysis of parental <italic>PAX6</italic> gene showed that all of the proband’s fathers have mutant allele fractions that range from 13 to 29%, depending on the tissue analysed, and have mild or no ocular features as compared to their affected offspring. Similarly, Bai et al. reported the presence of male gonadal mosaicism in a Chinese family with aniridia caused by PTC-inducing mutation c.879_880delCA, p.Ser294Cysfs*46 [<xref ref-type="bibr" rid="B109-genes-10-01050">109</xref>]. </p>
<p>The presence of parental mosaicism in <italic>PAX6</italic> contributes to partially explaining intra-familiar variabilities very often seen in patients. Furthermore, mosaicism is particularly relevant in sporadic aniridia cases, as it might be the underlying transmittance mechanism and not, in fact, <italic>de novo</italic> mutations, which has deep implications for genetic testing and counselling.</p>
</sec>
<sec id="sec6-genes-10-01050">
<title>6. Genotype-Phenotype Correlations</title>
<sec id="sec6dot1-genes-10-01050">
<title>6.1. Aniridia (MIM 106210)</title>
<p>Aniridia is a pan-ocular disorder that bilaterally affects the formation of the iris, cornea, lens, fovea, and optic nerve. Its prevalence is 1:40,000–100,000 with complete penetrance and variable expressivity [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>,<xref ref-type="bibr" rid="B100-genes-10-01050">100</xref>,<xref ref-type="bibr" rid="B111-genes-10-01050">111</xref>]. </p>
<p>The most obvious ocular feature is complete or partial iris hypoplasia, being accompanied by nystagmus and foveal hypoplasia, with the latter being the main cause of reduced visual acuity from birth. Further vision loss can occur from later onset cataracts, aniridia-related corneal keratopathy (ARK), and glaucoma (<xref ref-type="fig" rid="genes-10-01050-f004">Figure 4</xref>A–C). Cataracts tend to develop during the late teens to early adulthood in 50–85% of aniridia patients, while up to two-thirds of patients can develop glaucoma between late childhood and early adulthood [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>,<xref ref-type="bibr" rid="B112-genes-10-01050">112</xref>]. ARK is the most relevant feature contributing to visual loss in aniridia patients and it affects ~20% patients, but up to 90% can present with corneal irregularities [<xref ref-type="bibr" rid="B113-genes-10-01050">113</xref>]. Foveal hypoplasia and nystagmus were estimated to range between 85–95% of aniridia patients [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]. Optic nerve hypoplasia, although less common, is associated with ~10% of aniridia cases [<xref ref-type="bibr" rid="B90-genes-10-01050">90</xref>,<xref ref-type="bibr" rid="B114-genes-10-01050">114</xref>]. </p>
<p>However, aniridia patients can present with a wide phenotypic spectrum without clear correlation between genotype and phenotype, even in patients within the same family [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>]. Accordingly, a recent report from Pedersen et al. showed that family members with the same <italic>PAX6</italic> mutation, a 2 bp deletion in intron 2, presented with variable iris involvement, which ranged from almost normal to no iris, as well as different degrees of foveal hypoplasia [<xref ref-type="bibr" rid="B115-genes-10-01050">115</xref>,<xref ref-type="bibr" rid="B116-genes-10-01050">116</xref>]. In contrast, Lagali et al. recently found a correlation between <italic>PAX6</italic> variants and the severity and progression of ARK [<xref ref-type="bibr" rid="B117-genes-10-01050">117</xref>,<xref ref-type="bibr" rid="B118-genes-10-01050">118</xref>]. In a cohort of 46 aniridia patients, the authors found a minimal level of keratopathy and an increase in cornea thickness in all aniridia patients from early age. Patients with whole gene deletions presented the most severe and early onset ARK, followed by those with PTC or CTE mutations. Patients with missense mutations showed milder non-progressive ARK and, lastly, non-<italic>PAX6</italic> mutations had the mildest forms of disease and generally the best visual acuity [<xref ref-type="bibr" rid="B118-genes-10-01050">118</xref>]. However, the clinical phenotype of ARK is heterogenous and patients with the same mutation can often display different degrees of ARK. </p>
<p><italic>PAX6</italic> haploinsufficiency, which is caused by intragenic PTC-causing mutations, whole gene deletions, or inactivation of regulatory regions, is the cause of up to 85% of aniridia cases (<xref ref-type="fig" rid="genes-10-01050-f003">Figure 3</xref>B). Independent of the type or location of the PTC-containing transcripts, NMD is thought to be activated, resulting in null alleles. Iris hypoplasia is the most common feature in patients with mutations that cause <italic>PAX6</italic> haploinsufficiency, whereas patients with missense mutations tend to have less affected iris [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]. CTE variants usually translate to severe iris hypoplasia similar to PTCs, although Hingorani et al. examination of 10 patients with CTE showed that the iris phenotypes tend to be milder in these patients compared to patients with PTCs in the same study [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>,<xref ref-type="bibr" rid="B119-genes-10-01050">119</xref>]. </p>
<p>Aniridia-like phenotypes have been found in patients with rare variants in <italic>FOXC1</italic> and <italic>PITX2</italic> [<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>,<xref ref-type="bibr" rid="B120-genes-10-01050">120</xref>,<xref ref-type="bibr" rid="B121-genes-10-01050">121</xref>]. These genes are usually associated with anterior segment dysgenesis (ASD), which are characterized by iris hypoplasia (or atrophy) and corectopia, and, frequently, childhood-onset glaucoma. However, patients with ASD usually have better visual acuity than aniridia patients, without nystagmus or foveal abnormalities [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>,<xref ref-type="bibr" rid="B122-genes-10-01050">122</xref>]. In mice, <italic>Foxc1</italic> was recently found to be a downstream target of Pax6 in the iris, and the deletion of this gene also caused cornea neo-vascularisation, which indicated that both genes belong to a common network in the formation of the anterior segment [<xref ref-type="bibr" rid="B123-genes-10-01050">123</xref>,<xref ref-type="bibr" rid="B124-genes-10-01050">124</xref>]. Recently, missense mutations in <italic>TRIM44</italic> gene, located 4 Mb away from <italic>PAX6</italic>, were identified in a Chinese family with aniridia, cataracts and glaucoma [<xref ref-type="bibr" rid="B125-genes-10-01050">125</xref>]. TRIM44 was shown to negatively regulate <italic>PAX6</italic> expression, but only one pedigree was reported to date. </p>
<p>It is estimated that 5% of aniridia patients remain without molecular diagnosis, pointing to more <italic>PAX6</italic> regulatory regions, modifiers, or even novel genes to be discovered [<xref ref-type="bibr" rid="B102-genes-10-01050">102</xref>]. </p>
</sec>
<sec id="sec6dot2-genes-10-01050">
<title>6.2. WAGR (MIM 194072)</title>
<p>WAGR (Wilms tumour, Aniridia, Genitourinary abnormalities and mental Retardation) is an autosomal dominant disorder with a prevalence of 1:500,000 [<xref ref-type="bibr" rid="B15-genes-10-01050">15</xref>]. Chromosomal rearrangements or small deletions in 11p region encompassing <italic>PAX6</italic> and <italic>WT1</italic> loci cause it, but can be variable in size [<xref ref-type="bibr" rid="B71-genes-10-01050">71</xref>,<xref ref-type="bibr" rid="B126-genes-10-01050">126</xref>]. Approximately 30% of patients with sporadic aniridia suffer from this syndrome and diagnosed children have 50 to 70% risk of developing Wilms tumour involving the kidney, so regular screening is necessary for increasing the detection and obtaining better prognosis [<xref ref-type="bibr" rid="B127-genes-10-01050">127</xref>]. </p>
<p>While the absence of one copy of <italic>PAX6</italic> and <italic>WT1</italic> is established as the cause for aniridia and Wilms tumour (and genitourinary anomalies), respectively, the genetic causes that are behind the neurodevelopmental defects are less clear. Within the critical region in 11p, several genes have been associated with neurodevelopmental problems, like autism and ADHD. <italic>BDNF</italic>, a gene encoding the brain-derived neurotrophic factor, is located ~4 Mb from <italic>PAX6</italic> in 11p14.1. Patients with <italic>BDNF</italic> haploinsufficiency have variable degrees of developmental delay, as well as behavioural problems [<xref ref-type="bibr" rid="B128-genes-10-01050">128</xref>,<xref ref-type="bibr" rid="B129-genes-10-01050">129</xref>]. <italic>SLC1A2</italic>, encoding a glutamate transporter, and <italic>PRRG4</italic>, encoding a vitamin K-dependent membrane protein, are also located in 11p13-p12, a region that is identified by linkage analysis as an autism candidate region [<xref ref-type="bibr" rid="B130-genes-10-01050">130</xref>]. However, <italic>PAX6</italic> itself should also be considered, since some patients with <italic>PAX6</italic> intragenic mutations present with cerebral abnormalities as well as development delays and autism [<xref ref-type="bibr" rid="B16-genes-10-01050">16</xref>,<xref ref-type="bibr" rid="B17-genes-10-01050">17</xref>,<xref ref-type="bibr" rid="B131-genes-10-01050">131</xref>]. </p>
<p>WAGRO (MIM 612469) is a variant syndrome of WAGR that includes obesity [<xref ref-type="bibr" rid="B132-genes-10-01050">132</xref>,<xref ref-type="bibr" rid="B133-genes-10-01050">133</xref>]. Patients that were diagnosed with WAGRO have deletions that also encompass <italic>BDNF</italic>. <italic>BDNF</italic> is also involved in energy homeostasis in humans and haploinsufficiency is correlated with higher BMI (Body Mass Index), increased appetite, and childhood-onset obesity compared to WAGR patients without <italic>BDNF</italic> deletion [<xref ref-type="bibr" rid="B126-genes-10-01050">126</xref>,<xref ref-type="bibr" rid="B128-genes-10-01050">128</xref>].</p>
</sec>
<sec id="sec6dot3-genes-10-01050">
<title>6.3. Non-Aniridia Phenotypes</title>
<sec id="sec6dot3dot1-genes-10-01050">
<title>6.3.1. Isolated Foveal Hypoplasia</title>
<p>Isolated foveal hypoplasia, which is usually accompanied by nystagmus, has been described in few families with <italic>PAX6</italic> missense mutations in the paired domain: c.227C&gt;G, p.Pro76Arg and c.382C&gt;T, p.Arg128Cys [<xref ref-type="bibr" rid="B44-genes-10-01050">44</xref>,<xref ref-type="bibr" rid="B45-genes-10-01050">45</xref>,<xref ref-type="bibr" rid="B134-genes-10-01050">134</xref>]. These mutations are located in the CTS subdomain of PD, which modulates the DNA-binding activity of PAX6(5a) isoform [<xref ref-type="bibr" rid="B32-genes-10-01050">32</xref>]. It was previously reported that the PAX6(5a) isoform was highly expressed in the fovea, and that mutations in exon 5a, which affect CTS binding activity, also caused foveal hypoplasia (not isolated) [<xref ref-type="bibr" rid="B39-genes-10-01050">39</xref>]. These results point to foveal hypoplasia being linked to variants that affect the PAX6(5a) isoform in particular, but further experimental evidence is required to confirm this. However, it should also be noted that a missense (c.214G&gt;A, p.Gly72Ser) in the end of NTS and two PTC mutations in the PSTD (c.1035_1048del14, p.Pro346Aspfs*20 and c.1061_1070del10, p.Tyr354Cysfs*8) were also identified by Hingorani et al. in patients with foveal hypoplasia and mild structural abnormalities in the iris (<xref ref-type="fig" rid="genes-10-01050-f005">Figure 5</xref>) [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]. </p>
</sec>
<sec id="sec6dot3dot2-genes-10-01050">
<title>6.3.2. Microphthalmia, Anophthalmia and Coloboma (MAC)</title>
<p>MAC is a group of developmental eye disorders characterised by reduced size orabsence of the ocular globe and it is caused by mutations in more than 90 genes, including <italic>PAX6</italic> (<xref ref-type="fig" rid="genes-10-01050-f004">Figure 4</xref>) [<xref ref-type="bibr" rid="B92-genes-10-01050">92</xref>]. Of the 13 different mutations that are associated with microphthalmia in the <italic>PAX6</italic> Mutation Database, the vast majority (8) are missense, although PTC-inducing mutations have been reported (two nonsense and two frameshifts) (<xref ref-type="fig" rid="genes-10-01050-f005">Figure 5</xref>) [<xref ref-type="bibr" rid="B108-genes-10-01050">108</xref>,<xref ref-type="bibr" rid="B110-genes-10-01050">110</xref>,<xref ref-type="bibr" rid="B135-genes-10-01050">135</xref>,<xref ref-type="bibr" rid="B136-genes-10-01050">136</xref>]. Bilateral microphthalmia in a patient with WAGR syndrome was also identified [<xref ref-type="bibr" rid="B137-genes-10-01050">137</xref>].</p>
<p>MAC phenotypes are significantly associated with mutations that are likely to disrupt the PAX6-DNA interaction, with mutations being more common in the PD, which is the domain that is known to interact with SOX2 [<xref ref-type="bibr" rid="B67-genes-10-01050">67</xref>,<xref ref-type="bibr" rid="B138-genes-10-01050">138</xref>,<xref ref-type="bibr" rid="B139-genes-10-01050">139</xref>,<xref ref-type="bibr" rid="B140-genes-10-01050">140</xref>]. Mutations in <italic>SOX2</italic> are the most common cause of bilateral anophthalmia and severe microphthalmia [<xref ref-type="bibr" rid="B89-genes-10-01050">89</xref>,<xref ref-type="bibr" rid="B90-genes-10-01050">90</xref>]. Accordingly, a recent report has linked novel missense mutations in <italic>PAX6</italic> (c.160A&gt;C, p.Ser54Arg and c.372C&gt;A, p.Asn124Lys) to severe bilateral microphthalmia, with phenotype resembling <italic>SOX2</italic>-associated MAC [<xref ref-type="bibr" rid="B140-genes-10-01050">140</xref>]. The authors showed that these mutations significantly reduce the binding affinity of PAX6 to a specific regulatory sequence in the EE, LE9, which also synergistically responds to SOX2 [<xref ref-type="bibr" rid="B48-genes-10-01050">48</xref>]. This could lead to an inability of both PAX6 and SOX2 to cooperatively bind to LE9 or other target DNA sequences, which suggests that, aside from being required during lens development, the PAX6-SOX2 partnership can have an additional role earlier in eye field development.</p>
<p>Anophthalmia is associated with homozygous <italic>PAX6</italic> variants, where there is biallelic loss of function. The affected individuals are usually still births or die soon after birth with severe brain abnormalities [<xref ref-type="bibr" rid="B27-genes-10-01050">27</xref>,<xref ref-type="bibr" rid="B104-genes-10-01050">104</xref>]. </p>
<p>The most common form of ocular coloboma resulting from <italic>PAX6</italic> defects is that affecting the iris, which have been identified in patients with both nonsense, missense, and frameshift changes in <italic>PAX6</italic>, as well as the deletion of 3’regulatory region [<xref ref-type="bibr" rid="B141-genes-10-01050">141</xref>,<xref ref-type="bibr" rid="B142-genes-10-01050">142</xref>,<xref ref-type="bibr" rid="B143-genes-10-01050">143</xref>,<xref ref-type="bibr" rid="B144-genes-10-01050">144</xref>]. Optic nerve coloboma are generally associated with microphthalmia, with missense mutations affecting all of the functional domains of PAX6 (<xref ref-type="fig" rid="genes-10-01050-f005">Figure 5</xref>) [<xref ref-type="bibr" rid="B91-genes-10-01050">91</xref>,<xref ref-type="bibr" rid="B92-genes-10-01050">92</xref>]. It is thought that the inability of PAX6 to bind <italic>PAX2</italic> promoter and repress its expression in the optic cup during early eye development cause <italic>PAX6</italic>-related optic nerve anomalies. PAX2 is another PAX-family transcription factor that is mainly expressed in the optic stalk and represses <italic>PAX6</italic> expression in this region. This mutual repression is essential for defining the boundaries between the optic stalk, which will later form the optic nerve, and the optic cup [<xref ref-type="bibr" rid="B90-genes-10-01050">90</xref>,<xref ref-type="bibr" rid="B145-genes-10-01050">145</xref>].</p>
</sec>
<sec id="sec6dot3dot3-genes-10-01050">
<title>6.3.3. Gillespie Syndrome (MIM 206700)</title>
<p>Another syndrome with aniridia-like features is Gillespie syndrome (GS), which is a rare disorder that is characterized by nonprogressive cerebellar ataxia, intellectual disability, hypotonia, and iris hypoplasia with the presence of scalloped edges, fixed dilated pupils, and remnants of pupillary membrane [<xref ref-type="bibr" rid="B102-genes-10-01050">102</xref>]. Mutations in the <italic>ITPR1</italic> gene were identified as causative in GS [<xref ref-type="bibr" rid="B146-genes-10-01050">146</xref>,<xref ref-type="bibr" rid="B147-genes-10-01050">147</xref>]. However, a T&gt;A substitution in intron 2 of PAX6 was identified in two individuals that were described with Gillespie syndrome, but with atypical features, like corectopia and ptosis [<xref ref-type="bibr" rid="B148-genes-10-01050">148</xref>]. Later, a chromosomal deletion encompassing the 3’ regulatory region of PAX6 was also identified in a patient that was diagnosed with Gillespie syndrome [<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>].</p>
</sec>
<sec id="sec6dot3dot4-genes-10-01050">
<title>6.3.4. Anterior Segment Dysgenesis–Peters Anomaly (MIM 604229)</title>
<p>Peters anomaly is part of a larger spectrum of anterior segment dysgeneses characterized by abnormalities in the cornea, iris and lens, including central cornea opacity, defects in corneal stroma and Descemet’s membrane, and iridocorneal and corneolenticular adhesions [<xref ref-type="bibr" rid="B122-genes-10-01050">122</xref>]. Mutations in <italic>PAX6</italic>, but also <italic>PITX2</italic> and <italic>CYP1B1</italic>, have been identified in patients with Peters anomaly [<xref ref-type="bibr" rid="B122-genes-10-01050">122</xref>,<xref ref-type="bibr" rid="B149-genes-10-01050">149</xref>]. In the <italic>PAX6</italic> Mutation Database there are 11 different mutations associated with this syndrome: 10 are missense mutations, localized primarily in the PD, and one is a nonsense variant in the PSTD (<xref ref-type="fig" rid="genes-10-01050-f005">Figure 5</xref>) [<xref ref-type="bibr" rid="B33-genes-10-01050">33</xref>,<xref ref-type="bibr" rid="B45-genes-10-01050">45</xref>,<xref ref-type="bibr" rid="B149-genes-10-01050">149</xref>,<xref ref-type="bibr" rid="B150-genes-10-01050">150</xref>]. </p>
</sec>
</sec>
</sec>
<sec id="sec7-genes-10-01050" sec-type="conclusions">
<title>7. Conclusions</title>
<p>PAX6 plays a number of important roles both during eye development and maintenance of adult eye tissues. Defects in PAX6 lead to the perturbations in the dosage, time, and tissue specific expression, as well as disruption of its regulatory network. Due to this complex picture, individuals with mutations affecting <italic>PAX6</italic> present highly variable pan-ocular features, which makes genotype-phenotype correlations difficult to establish.</p>
<p>Developments in transcriptomics and epigenomics have allowed for increasing the understanding of PAX6 transcriptional targets, regulators, and interactors in the eye [<xref ref-type="bibr" rid="B12-genes-10-01050">12</xref>,<xref ref-type="bibr" rid="B151-genes-10-01050">151</xref>,<xref ref-type="bibr" rid="B152-genes-10-01050">152</xref>,<xref ref-type="bibr" rid="B153-genes-10-01050">153</xref>]. Accordingly, growing evidence supports the importance of <italic>PAX6</italic> regulation through microRNAs, as well as long non-coding RNAs [<xref ref-type="bibr" rid="B154-genes-10-01050">154</xref>,<xref ref-type="bibr" rid="B155-genes-10-01050">155</xref>,<xref ref-type="bibr" rid="B156-genes-10-01050">156</xref>,<xref ref-type="bibr" rid="B157-genes-10-01050">157</xref>,<xref ref-type="bibr" rid="B158-genes-10-01050">158</xref>,<xref ref-type="bibr" rid="B159-genes-10-01050">159</xref>]. These key advances mainly arose from mouse and <italic>Drosophila</italic> studies. However, it is still far from clear how PAX6 operates during eye development and how mutations translate into the variability of phenotypes that are described in this review. More representative models are needed for this purpose, and to overcome innate differences in eye development between human and other model organisms.</p>
<p>The generation of induced pluripotent stem cells (iPSCs)s allowed for the development of more representative in vitro models of human eye diseases, as well as of human eye development. This strategy would be particularly suitable for complex diseases, like aniridia, since iPSCs have the ability to differentiate into different cell types. Several ocular cell types where PAX6 activity is important have been successfully derived from iPSCs, like corneal and lens epithelial cells [<xref ref-type="bibr" rid="B157-genes-10-01050">157</xref>,<xref ref-type="bibr" rid="B160-genes-10-01050">160</xref>,<xref ref-type="bibr" rid="B161-genes-10-01050">161</xref>,<xref ref-type="bibr" rid="B162-genes-10-01050">162</xref>]. Additionally, iPSC-derived retinal organoids are now standardly used to study disease mechanisms and develop novel therapeutic approaches for eye disorders, like inherited retinal dystrophies [<xref ref-type="bibr" rid="B163-genes-10-01050">163</xref>,<xref ref-type="bibr" rid="B164-genes-10-01050">164</xref>,<xref ref-type="bibr" rid="B165-genes-10-01050">165</xref>,<xref ref-type="bibr" rid="B166-genes-10-01050">166</xref>,<xref ref-type="bibr" rid="B167-genes-10-01050">167</xref>]. However, this promising approach has not yet been applied to study <italic>PAX6</italic>- related eye diseases.</p>
<p>The majority of <italic>PAX6</italic> mutations result in null alleles and consequent <italic>PAX6</italic> haploinsufficiency and they are known to cause aniridia. Hence, understanding the <italic>PAX6</italic> dosage requirements in each affected tissue is of particular importance, not only to understand phenotypic outcomes, but also to predict therapeutic targets. Nonsense suppression therapy targets PTCs that are caused by nonsense mutations and bypasses them to produce full length protein [<xref ref-type="bibr" rid="B168-genes-10-01050">168</xref>]. A clinical trial on the oral administration of ataluren (PTC124) in aniridia patients is currently ongoing (NCT02647359), after promising results were seen in Sey<sup>+/−</sup> mice that were treated with this compound [<xref ref-type="bibr" rid="B169-genes-10-01050">169</xref>,<xref ref-type="bibr" rid="B170-genes-10-01050">170</xref>]. Postnatal administration of ataluren was shown to increase the levels of Pax6 protein up to 80% of control levels, improving lens and corneal epithelium morphology, as well as retina function, as shown by increased ERG responses. However, the exact mechanism of action of ataluren is still unknown, and there is criticism over the mode of drug administration, as topical/local application might permit lower dose, higher penetration, and less off-target effects. The results from the clinical trial are eagerly awaited.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to acknowledge Alex Yeong for helpful discussions and assistance with clinical data.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Writing: original draft preparation, D.L.C.; writing: review and editing, D.L.C., G.A., M.C., M.M.; funding acquisition, M.C., M.M.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded by Wellcome Trust (205174/Z/16/Z), National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Fight for Sight UK and Moorfields Eye Charity to M.M. GA is supported by a Fight for Sight UK Early Career Investigator Award, National Institute for Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital Institute of Child Health and Moorfields Eye Charity. MC is supported by the Spanish Institute of Health Carlos III (ISCIII)/European Regional Development Fund (ERDF) (PI17_01164 and CPII17_00006), the Regional Government of Madrid (CAM, B2017/BMD3721) and Spanish Federation of Rare Diseases (FEDER).</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-genes-10-01050">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callaerts</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Halder</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gehring</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>PAX-6 in development and evolution</article-title>
<source/>Annu. Rev. Neurosci.
          <year>1997</year>
<volume>20</volume>
<fpage>483</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.20.1.483</pub-id>
<pub-id pub-id-type="pmid">9056723</pub-id>
</element-citation>
</ref>
<ref id="B2-genes-10-01050">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ton</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Hirvonen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weil</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Monaghan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hastie</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Meijers-Heijboer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Drechsler</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region</article-title>
<source/>Cell
          <year>1991</year>
<volume>67</volume>
<fpage>1059</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(91)90284-6</pub-id>
<pub-id pub-id-type="pmid">1684738</pub-id>
</element-citation>
</ref>
<ref id="B3-genes-10-01050">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walther</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guenet</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Jostes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Goulding</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Plachov</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Balling</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gruss</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Pax: A murine multigene family of paired box-containing genes</article-title>
<source/>Genomics
          <year>1991</year>
<volume>11</volume>
<fpage>424</fpage>
<lpage>434</lpage>
<pub-id pub-id-type="doi">10.1016/0888-7543(91)90151-4</pub-id>
<pub-id pub-id-type="pmid">1685142</pub-id>
</element-citation>
</ref>
<ref id="B4-genes-10-01050">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Favor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Ton</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Prosser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hastie</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Mouse small eye results from mutations in a paired-like homeobox-containing gene</article-title>
<source/>Nature
          <year>1991</year>
<volume>354</volume>
<fpage>522</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1038/354522a0</pub-id>
<pub-id pub-id-type="pmid">1684639</pub-id>
</element-citation>
</ref>
<ref id="B5-genes-10-01050">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zaletayev</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hodgson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Prosser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hastie</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The human PAX6 gene is mutated in two patients with aniridia</article-title>
<source/>Nat. Genet.
          <year>1992</year>
<volume>1</volume>
<fpage>328</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1038/ng0892-328</pub-id>
<pub-id pub-id-type="pmid">1302030</pub-id>
</element-citation>
</ref>
<ref id="B6-genes-10-01050">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krauss</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Korzh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fjose</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Expression pattern of zebrafish pax genes suggests a role in early brain regionalization</article-title>
<source/>Nature
          <year>1991</year>
<volume>353</volume>
<fpage>267</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1038/353267a0</pub-id>
<pub-id pub-id-type="pmid">1680220</pub-id>
</element-citation>
</ref>
<ref id="B7-genes-10-01050">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carriere</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dozier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Quatannens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mirabel</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Vandenbunder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stehelin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Saule</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Characterization of a paired box- and homeobox-containing quail gene (Pax-QNR) expressed in the neuroretina</article-title>
<source/>Oncogene
          <year>1992</year>
<volume>7</volume>
<fpage>1721</fpage>
<lpage>1728</lpage>
<pub-id pub-id-type="pmid">1354346</pub-id>
</element-citation>
</ref>
<ref id="B8-genes-10-01050">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quiring</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Walldorf</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kloter</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gehring</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans</article-title>
<source/>Science
          <year>1994</year>
<volume>265</volume>
<fpage>785</fpage>
<lpage>789</lpage>
<pub-id pub-id-type="doi">10.1126/science.7914031</pub-id>
<pub-id pub-id-type="pmid">7914031</pub-id>
</element-citation>
</ref>
<ref id="B9-genes-10-01050">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halder</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Callaerts</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gehring</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila</article-title>
<source/>Science
          <year>1995</year>
<volume>267</volume>
<fpage>1788</fpage>
<lpage>1792</lpage>
<pub-id pub-id-type="doi">10.1126/science.7892602</pub-id>
<pub-id pub-id-type="pmid">7892602</pub-id>
</element-citation>
</ref>
<ref id="B10-genes-10-01050">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chow</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Altmann</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Hemmati-Brivanlou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Pax6 induces ectopic eyes in a vertebrate</article-title>
<source/>Development
          <year>1999</year>
<volume>126</volume>
<fpage>4213</fpage>
<lpage>4222</lpage>
<pub-id pub-id-type="pmid">10477290</pub-id>
</element-citation>
</ref>
<ref id="B11-genes-10-01050">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terzic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saraga-Babic</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Expression pattern of PAX3 and PAX6 genes during human embryogenesis</article-title>
<source/>Int. J. Dev. Biol.
          <year>1999</year>
<volume>43</volume>
<fpage>501</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">10610023</pub-id>
</element-citation>
</ref>
<ref id="B12-genes-10-01050">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaham</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Menuchin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Farhy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ashery-Padan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Pax6: A multi-level regulator of ocular development</article-title>
<source/>Prog. Retin. Eye Res.
          <year>2012</year>
<volume>31</volume>
<fpage>351</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/j.preteyeres.2012.04.002</pub-id>
<pub-id pub-id-type="pmid">22561546</pub-id>
</element-citation>
</ref>
<ref id="B13-genes-10-01050">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanescu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Iseli</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Schwerdtfeger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ittner</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Reme</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Hafezi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Continuous expression of the homeobox gene Pax6 in the ageing human retina</article-title>
<source/>Eye
          <year>2007</year>
<volume>21</volume>
<fpage>90</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1038/sj.eye.6702166</pub-id>
<pub-id pub-id-type="pmid">16254589</pub-id>
</element-citation>
</ref>
<ref id="B14-genes-10-01050">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hingorani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Moosajee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Clinical utility gene card for: Aniridia</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2016</year>
<volume>24</volume>
<fpage>1649</fpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2016.73</pub-id>
<pub-id pub-id-type="pmid">27381094</pub-id>
</element-citation>
</ref>
<ref id="B15-genes-10-01050">
<label>15.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Moosajee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hingorani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>PAX6-Related Aniridia</article-title>
<source/>GeneReviews((R))
          <person-group person-group-type="editor">
<name>
<surname>Adam</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Ardinger</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Pagon</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Bean</surname>
<given-names>L.J.H.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Amemiya</surname>
<given-names>A.</given-names>
</name>
</person-group>
<publisher-name>University of Washington</publisher-name>
<publisher-loc>Seattle, DC, USA</publisher-loc>
<year>2018</year>
</element-citation>
</ref>
<ref id="B16-genes-10-01050">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maekawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwayama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Toyota</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohnishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyachi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel missense mutation (Leu46Val) of PAX6 found in an autistic patient</article-title>
<source/>Neurosci. Lett.
          <year>2009</year>
<volume>462</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.07.021</pub-id>
<pub-id pub-id-type="pmid">19607881</pub-id>
</element-citation>
</ref>
<ref id="B17-genes-10-01050">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kikkawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Casingal</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hiraoka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Osumi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>The role of Pax6 in brain development and its impact on pathogenesis of autism spectrum disorder</article-title>
<source/>Brain Res.
          <year>2019</year>
<volume>1705</volume>
<fpage>95</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2018.02.041</pub-id>
<pub-id pub-id-type="pmid">29499177</pub-id>
</element-citation>
</ref>
<ref id="B18-genes-10-01050">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Rudd</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Librant</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Epping</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Sheffield</surname>
<given-names>V.C.</given-names>
</name>
<name>
<surname>Wassink</surname>
<given-names>T.H.</given-names>
</name>
</person-group>
<article-title>Pax6 3′ deletion results in aniridia, autism and mental retardation</article-title>
<source/>Hum. Genet.
          <year>2008</year>
<volume>123</volume>
<fpage>371</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-008-0484-x</pub-id>
<pub-id pub-id-type="pmid">18322702</pub-id>
</element-citation>
</ref>
<ref id="B19-genes-10-01050">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hergott-Faure</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Borot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kleinclauss</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Abitbol</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Penfornis</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Pituitary function and glucose tolerance in a family with a PAX6 mutation</article-title>
<source/>Ann. D’Endocrinol.
          <year>2012</year>
<volume>73</volume>
<fpage>510</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1016/j.ando.2012.10.001</pub-id>
</element-citation>
</ref>
<ref id="B20-genes-10-01050">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xatzipsalti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Voutetakis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stamoyannou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chrousos</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Kanaka-Gantenbein</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Congenital Hypopituitarism: Various Genes, Various Phenotypes</article-title>
<source/>Horm. Metab. Res.
          <year>2019</year>
<volume>51</volume>
<fpage>81</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1055/a-0822-3637</pub-id>
<pub-id pub-id-type="pmid">30759489</pub-id>
</element-citation>
</ref>
<ref id="B21-genes-10-01050">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanish</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Butman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Pineal hypoplasia, reduced melatonin and sleep disturbance in patients with PAX6 haploinsufficiency</article-title>
<source/>J. Sleep Res.
          <year>2016</year>
<volume>25</volume>
<fpage>16</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1111/jsr.12345</pub-id>
<pub-id pub-id-type="pmid">26439359</pub-id>
</element-citation>
</ref>
<ref id="B22-genes-10-01050">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Free</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Churchill</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Shorvon</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sisodiya</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Polymicrogyria and absence of pineal gland due to PAX6 mutation</article-title>
<source/>Ann. Neurol.
          <year>2003</year>
<volume>53</volume>
<fpage>658</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10576</pub-id>
<pub-id pub-id-type="pmid">12731001</pub-id>
</element-citation>
</ref>
<ref id="B23-genes-10-01050">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boese</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Tollefson</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Schnieders</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Darbro</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Alward</surname>
<given-names>W.L.M.</given-names>
</name>
<name>
<surname>Fingert</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Novel Intragenic PAX6 Deletion in a Pedigree with Aniridia, Morbid Obesity, and Diabetes</article-title>
<source/>Curr. Eye Res.
          <year>2020</year>
<volume>45</volume>
<fpage>91</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1080/02713683.2019.1649704</pub-id>
<pub-id pub-id-type="pmid">31361967</pub-id>
</element-citation>
</ref>
<ref id="B24-genes-10-01050">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panneerselvam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mariajoseph-Antony</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Prahalathan</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>PAX proteins and their role in pancreas</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2019</year>
<volume>155</volume>
<fpage>107792</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2019.107792</pub-id>
<pub-id pub-id-type="pmid">31325538</pub-id>
</element-citation>
</ref>
<ref id="B25-genes-10-01050">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schedl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Danes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6</article-title>
<source/>Hum. Mol. Genet.
          <year>2001</year>
<volume>10</volume>
<fpage>2049</fpage>
<lpage>2059</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.19.2049</pub-id>
<pub-id pub-id-type="pmid">11590122</pub-id>
</element-citation>
</ref>
<ref id="B26-genes-10-01050">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bengani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fish</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Divizia</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>de Marco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Damante</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Grainger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia</article-title>
<source/>Am. J. Hum. Genet.
          <year>2013</year>
<volume>93</volume>
<fpage>1126</fpage>
<lpage>1134</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.10.028</pub-id>
<pub-id pub-id-type="pmid">24290376</pub-id>
</element-citation>
</ref>
<ref id="B27-genes-10-01050">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene</article-title>
<source/>Nat. Genet.
          <year>1992</year>
<volume>2</volume>
<fpage>232</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1038/ng1192-232</pub-id>
<pub-id pub-id-type="pmid">1345175</pub-id>
</element-citation>
</ref>
<ref id="B28-genes-10-01050">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruun</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Thomassen</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Kristiansen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tylden</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mikkola</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bjorkoy</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The third helix of the homeodomain of paired class homeodomain proteins acts as a recognition helix both for DNA and protein interactions</article-title>
<source/>Nucleic Acids Res.
          <year>2005</year>
<volume>33</volume>
<fpage>2661</fpage>
<lpage>2675</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gki562</pub-id>
<pub-id pub-id-type="pmid">15886395</pub-id>
</element-citation>
</ref>
<ref id="B29-genes-10-01050">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Missense mutation at the C-terminus of PAX6 negatively modulates homeodomain function</article-title>
<source/>Hum. Mol. Genet.
          <year>2001</year>
<volume>10</volume>
<fpage>911</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.9.911</pub-id>
<pub-id pub-id-type="pmid">11309364</pub-id>
</element-citation>
</ref>
<ref id="B30-genes-10-01050">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Dissection of the transactivation function of the transcription factor encoded by the eye developmental gene PAX6</article-title>
<source/>J. Biol. Chem.
          <year>1998</year>
<volume>273</volume>
<fpage>7210</fpage>
<lpage>7221</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.13.7210</pub-id>
<pub-id pub-id-type="pmid">9516413</pub-id>
</element-citation>
</ref>
<ref id="B31-genes-10-01050">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epstein</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jepeal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing</article-title>
<source/>Genes Dev.
          <year>1994</year>
<volume>8</volume>
<fpage>2022</fpage>
<lpage>2034</lpage>
<pub-id pub-id-type="doi">10.1101/gad.8.17.2022</pub-id>
<pub-id pub-id-type="pmid">7958875</pub-id>
</element-citation>
</ref>
<ref id="B32-genes-10-01050">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epstein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jepeal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes</article-title>
<source/>J. Biol. Chem.
          <year>1994</year>
<volume>269</volume>
<fpage>8355</fpage>
<lpage>8361</lpage>
<pub-id pub-id-type="pmid">8132558</pub-id>
</element-citation>
</ref>
<ref id="B33-genes-10-01050">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Handa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Missense mutation in the alternative splice region of the PAX6 gene in eye anomalies</article-title>
<source/>Am. J. Hum. Genet.
          <year>1999</year>
<volume>65</volume>
<fpage>656</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.1086/302529</pub-id>
<pub-id pub-id-type="pmid">10441571</pub-id>
</element-citation>
</ref>
<ref id="B34-genes-10-01050">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lauderdale</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less isoform of Pax6 in the eye and olfactory bulb</article-title>
<source/>Dev. Biol.
          <year>2006</year>
<volume>292</volume>
<fpage>486</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.12.041</pub-id>
<pub-id pub-id-type="pmid">16464444</pub-id>
</element-citation>
</ref>
<ref id="B35-genes-10-01050">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carriere</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Plaza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Quatannens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bailly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stehelin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Saule</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina</article-title>
<source/>Mol. Cell. Biol.
          <year>1993</year>
<volume>13</volume>
<fpage>7257</fpage>
<lpage>7266</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.13.12.7257</pub-id>
<pub-id pub-id-type="pmid">8246948</pub-id>
</element-citation>
</ref>
<ref id="B36-genes-10-01050">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lauderdale</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Overexpression of pairedless Pax6 in the retina disrupts corneal development and affects lens cell survival</article-title>
<source/>Dev. Biol.
          <year>2008</year>
<volume>313</volume>
<fpage>434</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2007.10.043</pub-id>
<pub-id pub-id-type="pmid">18062951</pub-id>
</element-citation>
</ref>
<ref id="B37-genes-10-01050">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mella</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Tyas</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Long-range downstream enhancers are essential for Pax6 expression</article-title>
<source/>Dev. Biol.
          <year>2006</year>
<volume>299</volume>
<fpage>563</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2006.08.060</pub-id>
<pub-id pub-id-type="pmid">17014839</pub-id>
</element-citation>
</ref>
<ref id="B38-genes-10-01050">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakowski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Majumder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lauderdale</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Mechanisms controlling Pax6 isoform expression in the retina have been conserved between teleosts and mammals</article-title>
<source/>Dev. Biol.
          <year>2007</year>
<volume>307</volume>
<fpage>498</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2007.04.015</pub-id>
<pub-id pub-id-type="pmid">17509554</pub-id>
</element-citation>
</ref>
<ref id="B39-genes-10-01050">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tadokoro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Handa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kohsaka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kida</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Pax6 isoform bearing an alternative spliced exon promotes the development of the neural retinal structure</article-title>
<source/>Hum. Mol. Genet.
          <year>2005</year>
<volume>14</volume>
<fpage>735</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddi069</pub-id>
<pub-id pub-id-type="pmid">15677484</pub-id>
</element-citation>
</ref>
<ref id="B40-genes-10-01050">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferres-Marco</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gutierrez-Avino</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Speicher</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Beneyto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Growth and specification of the eye are controlled independently by Eyegone and Eyeless in Drosophila melanogaster</article-title>
<source/>Nat. Genet.
          <year>2004</year>
<volume>36</volume>
<fpage>31</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1038/ng1281</pub-id>
<pub-id pub-id-type="pmid">14702038</pub-id>
</element-citation>
</ref>
<ref id="B41-genes-10-01050">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>P.X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Heaney</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Michelson</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Regulation of Pax6 expression is conserved between mice and flies</article-title>
<source/>Development
          <year>1999</year>
<volume>126</volume>
<fpage>383</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="pmid">9847251</pub-id>
</element-citation>
</ref>
<ref id="B42-genes-10-01050">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cveklova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oppermann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kantorow</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Quantitation of PAX6 and PAX6 (5a) transcript levels in adult human lens, cornea, and monkey retina</article-title>
<source/>Mol. Vis.
          <year>2001</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">11172136</pub-id>
</element-citation>
</ref>
<ref id="B43-genes-10-01050">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Callaerts</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>PAX6: 25th anniversary and more to learn</article-title>
<source/>Exp. Eye Res.
          <year>2017</year>
<volume>156</volume>
<fpage>10</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.exer.2016.04.017</pub-id>
<pub-id pub-id-type="pmid">27126352</pub-id>
</element-citation>
</ref>
<ref id="B44-genes-10-01050">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishina</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Okuyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>PAX6 missense mutation in isolated foveal hypoplasia</article-title>
<source/>Nat. Genet.
          <year>1996</year>
<volume>13</volume>
<fpage>141</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1038/ng0696-141</pub-id>
<pub-id pub-id-type="pmid">8640214</pub-id>
</element-citation>
</ref>
<ref id="B45-genes-10-01050">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>PAX6 in sensory development</article-title>
<source/>Hum. Mol. Genet.
          <year>2002</year>
<volume>11</volume>
<fpage>1161</fpage>
<lpage>1167</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/11.10.1161</pub-id>
<pub-id pub-id-type="pmid">12015275</pub-id>
</element-citation>
</ref>
<ref id="B46-genes-10-01050">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Saito-Adachi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Quantock</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsujikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>PAX6 Isoforms, along with Reprogramming Factors, Differentially Regulate the Induction of Cornea-specific Genes</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>20807</fpage>
<pub-id pub-id-type="doi">10.1038/srep20807</pub-id>
<pub-id pub-id-type="pmid">26899008</pub-id>
</element-citation>
</ref>
<ref id="B47-genes-10-01050">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Positive autoregulation of the transcription factor Pax6 in response to increased levels of either of its major isoforms, Pax6 or Pax6 (5a), in cultured cells</article-title>
<source/>BMC Dev. Biol.
          <year>2006</year>
<volume>6</volume>
<elocation-id>25</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-213X-6-25</pub-id>
<pub-id pub-id-type="pmid">16725027</pub-id>
</element-citation>
</ref>
<ref id="B48-genes-10-01050">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aota</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ibaraki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Okazaki</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Pax6 autoregulation mediated by direct interaction of Pax6 protein with the head surface ectoderm-specific enhancer of the mouse Pax6 gene</article-title>
<source/>Dev. Biol.
          <year>2003</year>
<volume>257</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/S0012-1606(03)00058-7</pub-id>
<pub-id pub-id-type="pmid">12710953</pub-id>
</element-citation>
</ref>
<ref id="B49-genes-10-01050">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dora</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kucerova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parisi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Collinson</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>PAX6 dosage effects on corneal development, growth, and wound healing</article-title>
<source/>Dev. Dyn. Off. Publ. Am. Assoc. Anat.
          <year>2008</year>
<volume>237</volume>
<fpage>1295</fpage>
<lpage>1306</lpage>
<pub-id pub-id-type="doi">10.1002/dvdy.21528</pub-id>
</element-citation>
</ref>
<ref id="B50-genes-10-01050">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Regulation of the Pax6: Pax6 (5a) mRNA ratio in the developing mammalian brain</article-title>
<source/>BMC Dev. Biol.
          <year>2005</year>
<volume>5</volume>
<elocation-id>13</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-213X-5-13</pub-id>
<pub-id pub-id-type="pmid">16029501</pub-id>
</element-citation>
</ref>
<ref id="B51-genes-10-01050">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chauhan</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cveklova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Functional interactions between alternatively spliced forms of Pax6 in crystallin gene regulation and in haploinsufficiency</article-title>
<source/>Nucleic Acids Res.
          <year>2004</year>
<volume>32</volume>
<fpage>1696</fpage>
<lpage>1709</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkh334</pub-id>
<pub-id pub-id-type="pmid">15020706</pub-id>
</element-citation>
</ref>
<ref id="B52-genes-10-01050">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dozier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Langlois</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Saule</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Identification and characterization of a neuroretina-specific enhancer element in the quail Pax-6 (Pax-QNR) gene</article-title>
<source/>Mol. Cell. Biol.
          <year>1995</year>
<volume>15</volume>
<fpage>892</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.15.2.892</pub-id>
<pub-id pub-id-type="pmid">7529875</pub-id>
</element-citation>
</ref>
<ref id="B53-genes-10-01050">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dozier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Turque</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saule</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Quail Pax-6 (Pax-QNR) mRNAs are expressed from two promoters used differentially during retina development and neuronal differentiation</article-title>
<source/>Mol. Cell. Biol.
          <year>1995</year>
<volume>15</volume>
<fpage>3344</fpage>
<lpage>3353</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.15.6.3344</pub-id>
<pub-id pub-id-type="pmid">7760830</pub-id>
</element-citation>
</ref>
<ref id="B54-genes-10-01050">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kammandel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stoykova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aparicio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gruss</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity</article-title>
<source/>Dev. Biol.
          <year>1999</year>
<volume>205</volume>
<fpage>79</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1006/dbio.1998.9128</pub-id>
<pub-id pub-id-type="pmid">9882499</pub-id>
</element-citation>
</ref>
<ref id="B55-genes-10-01050">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.P.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Transcriptional regulation of the human PAX6 gene promoter</article-title>
<source/>J. Biol. Chem.
          <year>1997</year>
<volume>272</volume>
<fpage>3430</fpage>
<lpage>3436</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.6.3430</pub-id>
<pub-id pub-id-type="pmid">9013587</pub-id>
</element-citation>
</ref>
<ref id="B56-genes-10-01050">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Monahan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ravi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>A survey of ancient conserved non-coding elements in the PAX6 locus reveals a landscape of interdigitated cis-regulatory archipelagos</article-title>
<source/>Dev. Biol.
          <year>2014</year>
<volume>387</volume>
<fpage>214</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2014.01.007</pub-id>
<pub-id pub-id-type="pmid">24440152</pub-id>
</element-citation>
</ref>
<ref id="B57-genes-10-01050">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Buckle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>DNaseI hypersensitivity and ultraconservation reveal novel, interdependent long-range enhancers at the complex Pax6 cis-regulatory region</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e28616</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0028616</pub-id>
<pub-id pub-id-type="pmid">22220192</pub-id>
</element-citation>
</ref>
<ref id="B58-genes-10-01050">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Doe</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>New 3′ elements control Pax6 expression in the developing pretectum, neural retina and olfactory region</article-title>
<source/>Mech. Dev.
          <year>2002</year>
<volume>112</volume>
<fpage>89</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1016/S0925-4773(01)00646-3</pub-id>
<pub-id pub-id-type="pmid">11850181</pub-id>
</element-citation>
</ref>
<ref id="B59-genes-10-01050">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Childs</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Conserved elements in Pax6 intron 7 involved in (auto)regulation and alternative transcription</article-title>
<source/>Dev. Biol.
          <year>2004</year>
<volume>265</volume>
<fpage>462</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2003.09.011</pub-id>
<pub-id pub-id-type="pmid">14732405</pub-id>
</element-citation>
</ref>
<ref id="B60-genes-10-01050">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Altmann</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Hemmati-Brivanlou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>A highly conserved lens transcriptional control element from the Pax-6 gene</article-title>
<source/>Mech. Dev.
          <year>1998</year>
<volume>73</volume>
<fpage>225</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1016/S0925-4773(98)00057-4</pub-id>
<pub-id pub-id-type="pmid">9622640</pub-id>
</element-citation>
</ref>
<ref id="B61-genes-10-01050">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vance</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Sansom</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chalei</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Ponting</surname>
<given-names>C.P.</given-names>
</name>
</person-group>
<article-title>The long non-coding RNA Paupar regulates the expression of both local and distal genes</article-title>
<source/>EMBO J.
          <year>2014</year>
<volume>33</volume>
<fpage>296</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1002/embj.201386225</pub-id>
<pub-id pub-id-type="pmid">24488179</pub-id>
</element-citation>
</ref>
<ref id="B62-genes-10-01050">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buckle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nozawa</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Kleinjan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Functional characteristics of novel pancreatic Pax6 regulatory elements</article-title>
<source/>Hum. Mol. Genet.
          <year>2018</year>
<volume>27</volume>
<fpage>3434</fpage>
<lpage>3448</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddy255</pub-id>
<pub-id pub-id-type="pmid">30007277</pub-id>
</element-citation>
</ref>
<ref id="B63-genes-10-01050">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Loosli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Coutinho</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequencing of Pax6 loci from the elephant shark reveals a family of Pax6 genes in vertebrate genomes, forged by ancient duplications and divergences</article-title>
<source/>PLoS Genet.
          <year>2013</year>
<volume>9</volume>
<elocation-id>e1003177</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003177</pub-id>
<pub-id pub-id-type="pmid">23359656</pub-id>
</element-citation>
</ref>
<ref id="B64-genes-10-01050">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimanlig</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Faber</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Auerbach</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Makarenkova</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>The upstream ectoderm enhancer in Pax6 has an important role in lens induction</article-title>
<source/>Development
          <year>2001</year>
<volume>128</volume>
<fpage>4415</fpage>
<lpage>4424</lpage>
<pub-id pub-id-type="pmid">11714668</pub-id>
</element-citation>
</ref>
<ref id="B65-genes-10-01050">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Siggers</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lachke</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bulyk</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity</article-title>
<source/>Genes Dev.
          <year>2010</year>
<volume>24</volume>
<fpage>980</fpage>
<lpage>985</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1890410</pub-id>
<pub-id pub-id-type="pmid">20413611</pub-id>
</element-citation>
</ref>
<ref id="B66-genes-10-01050">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goudreau</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Petrou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reneker</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Graw</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Loster</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gruss</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Mutually regulated expression of Pax6 and Six3 and its implications for the Pax6 haploinsufficient lens phenotype</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>8719</fpage>
<lpage>8724</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.132195699</pub-id>
<pub-id pub-id-type="pmid">12072567</pub-id>
</element-citation>
</ref>
<ref id="B67-genes-10-01050">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kamachi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsunami</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Imada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Uchikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>PAX6 and SOX2-dependent regulation of the Sox2 enhancer N-3 involved in embryonic visual system development</article-title>
<source/>Genes Cells Devoted Mol. Cell. Mech.
          <year>2007</year>
<volume>12</volume>
<fpage>1049</fpage>
<lpage>1061</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2443.2007.01114.x</pub-id>
</element-citation>
</ref>
<ref id="B68-genes-10-01050">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauderdale</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Wilensky</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>3′ deletions cause aniridia by preventing PAX6 gene expression</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2000</year>
<volume>97</volume>
<fpage>13755</fpage>
<lpage>13759</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.240398797</pub-id>
<pub-id pub-id-type="pmid">11087823</pub-id>
</element-citation>
</ref>
<ref id="B69-genes-10-01050">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heaney</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis</article-title>
<source/>Genes Dev.
          <year>2002</year>
<volume>16</volume>
<fpage>2097</fpage>
<lpage>2107</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1007602</pub-id>
<pub-id pub-id-type="pmid">12183364</pub-id>
</element-citation>
</ref>
<ref id="B70-genes-10-01050">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antosova</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Smolikova</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klimova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lachova</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bendova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kozmikova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Machon</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kozmik</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The Gene Regulatory Network of Lens Induction Is Wired through Meis-Dependent Shadow Enhancers of Pax6</article-title>
<source/>PLoS Genet.
          <year>2016</year>
<volume>12</volume>
<elocation-id>e1006441</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006441</pub-id>
<pub-id pub-id-type="pmid">27918583</pub-id>
</element-citation>
</ref>
<ref id="B71-genes-10-01050">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanco-Kelly</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Palomares</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vallespin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Villaverde</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martin-Arenas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Velez-Monsalve</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lorda-Sanchez</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nevado</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trujillo-Tiebas</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lapunzina</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving molecular diagnosis of aniridia and WAGR syndrome using customized targeted array-based CGH</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<elocation-id>e0172363</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0172363</pub-id>
<pub-id pub-id-type="pmid">28231309</pub-id>
</element-citation>
</ref>
<ref id="B72-genes-10-01050">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ansari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rainger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Harewood</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sandilands</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clayton-Smith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dollfus</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bitoun</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic Analysis of ‘PAX6-Negative’ Individuals with Aniridia or Gillespie Syndrome</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0153757</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0153757</pub-id>
<pub-id pub-id-type="pmid">27124303</pub-id>
</element-citation>
</ref>
<ref id="B73-genes-10-01050">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syrimis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nicolaou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Alexandrou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Papaevripidou</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nicolaou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Loukianou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Christophidou-Anastasiadou</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Malas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sismani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tanteles</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Aniridia due to a novel microdeletion affecting PAX6 regulatory enhancers: Case report and review of the literature</article-title>
<source/>J. Genet.
          <year>2018</year>
<volume>97</volume>
<fpage>555</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1007/s12041-018-0925-9</pub-id>
<pub-id pub-id-type="pmid">29932076</pub-id>
</element-citation>
</ref>
<ref id="B74-genes-10-01050">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macdonald</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Hesselson</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Laybutt</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Hesselson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>L.V.</given-names>
</name>
</person-group>
<article-title>Deletion distal to the PAX6 coding region reveals a novel basis for familial cosegregation of aniridia and diabetes mellitus</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2019</year>
<volume>148</volume>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2018.12.002</pub-id>
<pub-id pub-id-type="pmid">30572005</pub-id>
</element-citation>
</ref>
<ref id="B75-genes-10-01050">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaisancie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tarilonte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jeanton-Scaramouche</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gaston</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dollfus</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aguilera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fares-Taie</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Blanco-Kelly</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implication of non-coding PAX6 mutations in aniridia</article-title>
<source/>Hum. Genet.
          <year>2018</year>
<volume>137</volume>
<fpage>831</fpage>
<lpage>846</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-018-1940-x</pub-id>
<pub-id pub-id-type="pmid">30291432</pub-id>
</element-citation>
</ref>
<ref id="B76-genes-10-01050">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayrakli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guney</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bayri</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ercan-Sencicek</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Ceyhan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cankaya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bilguvar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bayrakli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>S.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel heterozygous deletion within the 3’ region of the PAX6 gene causing isolated aniridia in a large family group</article-title>
<source/>J. Clin. Neurosci.
          <year>2009</year>
<volume>16</volume>
<fpage>1610</fpage>
<lpage>1614</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocn.2009.03.022</pub-id>
<pub-id pub-id-type="pmid">19793656</pub-id>
</element-citation>
</ref>
<ref id="B77-genes-10-01050">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Addis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dixit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ogilvie</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vaags</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation</article-title>
<source/>Hum. Mutat.
          <year>2015</year>
<volume>36</volume>
<fpage>842</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22816</pub-id>
<pub-id pub-id-type="pmid">26010655</pub-id>
</element-citation>
</ref>
<ref id="B78-genes-10-01050">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tzoulaki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
</person-group>
<article-title>PAX6 mutations: Genotype-phenotype correlations</article-title>
<source/>BMC Genet.
          <year>2005</year>
<volume>6</volume>
<elocation-id>27</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2156-6-27</pub-id>
<pub-id pub-id-type="pmid">15918896</pub-id>
</element-citation>
</ref>
<ref id="B79-genes-10-01050">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kervestin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>NMD: At the crossroads between translation termination and ribosome recycling</article-title>
<source/>Biochimie
          <year>2015</year>
<volume>114</volume>
<fpage>2</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2014.10.027</pub-id>
<pub-id pub-id-type="pmid">25446649</pub-id>
</element-citation>
</ref>
<ref id="B80-genes-10-01050">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Pujo</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Calvas</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Screening for PAX6 gene mutations is consistent with haploinsufficiency as the main mechanism leading to various ocular defects</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2003</year>
<volume>11</volume>
<fpage>163</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5200940</pub-id>
<pub-id pub-id-type="pmid">12634864</pub-id>
</element-citation>
</ref>
<ref id="B81-genes-10-01050">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Truncation mutations in the transactivation region of PAX6 result in dominant-negative mutants</article-title>
<source/>J. Biol. Chem.
          <year>1998</year>
<volume>273</volume>
<fpage>21531</fpage>
<lpage>21541</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.34.21531</pub-id>
<pub-id pub-id-type="pmid">9705283</pub-id>
</element-citation>
</ref>
<ref id="B82-genes-10-01050">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khajavi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ohyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hirabayashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reggin</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Mancias</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Wegner</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations</article-title>
<source/>Nat. Genet.
          <year>2004</year>
<volume>36</volume>
<fpage>361</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1038/ng1322</pub-id>
<pub-id pub-id-type="pmid">15004559</pub-id>
</element-citation>
</ref>
<ref id="B83-genes-10-01050">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasilyeva</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Voskresenskaya</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Kasmann-Kellner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Khlebnikova</surname>
<given-names>O.V.</given-names>
</name>
<name>
<surname>Pozdeyeva</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Bayazutdinova</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Kutsev</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Ginter</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Semina</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Marakhonov</surname>
<given-names>A.V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations</article-title>
<source/>Clin. Genet.
          <year>2017</year>
<volume>92</volume>
<fpage>639</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1111/cge.13019</pub-id>
<pub-id pub-id-type="pmid">28321846</pub-id>
</element-citation>
</ref>
<ref id="B84-genes-10-01050">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>D.O.</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Beal</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Crolla</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia</article-title>
<source/>Am. J. Med. Genet. Part A
          <year>2008</year>
<volume>146</volume>
<fpage>558</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.32209</pub-id>
<pub-id pub-id-type="pmid">18241071</pub-id>
</element-citation>
</ref>
<ref id="B85-genes-10-01050">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobilev</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>McDougal</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Geisert</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Netland</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Lauderdale</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Assessment of PAX6 alleles in 66 families with aniridia</article-title>
<source/>Clin. Genet.
          <year>2016</year>
<volume>89</volume>
<fpage>669</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12708</pub-id>
<pub-id pub-id-type="pmid">26661695</pub-id>
</element-citation>
</ref>
<ref id="B86-genes-10-01050">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hingorani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2009</year>
<volume>50</volume>
<fpage>2581</fpage>
<lpage>2590</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.08-2827</pub-id>
<pub-id pub-id-type="pmid">19218613</pub-id>
</element-citation>
</ref>
<ref id="B87-genes-10-01050">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Missense mutations in the DNA-binding region and termination codon in PAX6</article-title>
<source/>Hum. Mutat.
          <year>2003</year>
<volume>21</volume>
<fpage>138</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1002/humu.10163</pub-id>
<pub-id pub-id-type="pmid">12552561</pub-id>
</element-citation>
</ref>
<ref id="B88-genes-10-01050">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Functional analysis of paired box missense mutations in the PAX6 gene</article-title>
<source/>Hum. Mol. Genet.
          <year>1997</year>
<volume>6</volume>
<fpage>381</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/6.3.381</pub-id>
<pub-id pub-id-type="pmid">9147640</pub-id>
</element-citation>
</ref>
<ref id="B89-genes-10-01050">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
</person-group>
<article-title>PAX6 and congenital eye malformations</article-title>
<source/>Pediatr. Res.
          <year>2003</year>
<volume>54</volume>
<fpage>791</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1203/01.PDR.0000096455.00657.98</pub-id>
<pub-id pub-id-type="pmid">14561779</pub-id>
</element-citation>
</ref>
<ref id="B90-genes-10-01050">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Handa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tadokoro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kawase</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations</article-title>
<source/>Am. J. Hum. Genet.
          <year>2003</year>
<volume>72</volume>
<fpage>1565</fpage>
<lpage>1570</lpage>
<pub-id pub-id-type="doi">10.1086/375555</pub-id>
<pub-id pub-id-type="pmid">12721955</pub-id>
</element-citation>
</ref>
<ref id="B91-genes-10-01050">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>FitzPatrick</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>The genetic architecture of microphthalmia, anophthalmia and coloboma</article-title>
<source/>Eur. J. Med. Genet.
          <year>2014</year>
<volume>57</volume>
<fpage>369</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2014.05.002</pub-id>
<pub-id pub-id-type="pmid">24859618</pub-id>
</element-citation>
</ref>
<ref id="B92-genes-10-01050">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harding</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moosajee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Molecular Basis of Human Anophthalmia and Microphthalmia</article-title>
<source/>J. Dev. Biol.
          <year>2019</year>
<volume>7</volume>
<elocation-id>16</elocation-id>
<pub-id pub-id-type="doi">10.3390/jdb7030016</pub-id>
<pub-id pub-id-type="pmid">31416264</pub-id>
</element-citation>
</ref>
<ref id="B93-genes-10-01050">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deml</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Lemyre</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Kariminejad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Semina</surname>
<given-names>E.V.</given-names>
</name>
</person-group>
<article-title>Novel mutations in PAX6, OTX2 and NDP in anophthalmia, microphthalmia and coloboma</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2016</year>
<volume>24</volume>
<fpage>535</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2015.155</pub-id>
<pub-id pub-id-type="pmid">26130484</pub-id>
</element-citation>
</ref>
<ref id="B94-genes-10-01050">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perenthaler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yousefi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Niggl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barakat</surname>
<given-names>T.S.</given-names>
</name>
</person-group>
<article-title>Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development</article-title>
<source/>Front. Cell. Neurosci.
          <year>2019</year>
<volume>13</volume>
<fpage>352</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2019.00352</pub-id>
<pub-id pub-id-type="pmid">31417368</pub-id>
</element-citation>
</ref>
<ref id="B95-genes-10-01050">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Protas</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Weh</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Footz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kasberger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Ritch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Semina</surname>
<given-names>E.V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma</article-title>
<source/>Hum. Mol. Genet.
          <year>2017</year>
<volume>26</volume>
<fpage>3630</fpage>
<lpage>3638</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddx251</pub-id>
<pub-id pub-id-type="pmid">28911203</pub-id>
</element-citation>
</ref>
<ref id="B96-genes-10-01050">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenberger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Neuhaus</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Decker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Preising</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Friedburg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bieg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gliem</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Charbel Issa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Holz</surname>
<given-names>F.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: The example of retinal dystrophies</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e78496</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0078496</pub-id>
<pub-id pub-id-type="pmid">24265693</pub-id>
</element-citation>
</ref>
<ref id="B97-genes-10-01050">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gronskov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sand</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brondum-Nielsen</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype</article-title>
<source/>Eur. J. Hum. Genet.
          <year>1999</year>
<volume>7</volume>
<fpage>274</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5200308</pub-id>
<pub-id pub-id-type="pmid">10234503</pub-id>
</element-citation>
</ref>
<ref id="B98-genes-10-01050">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Axton</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prosser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Combined SSCP/heteroduplex analysis in the screening for PAX6 mutations</article-title>
<source/>Mol. Cell. Probes
          <year>1997</year>
<volume>11</volume>
<fpage>287</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1006/mcpr.1997.0117</pub-id>
<pub-id pub-id-type="pmid">9281415</pub-id>
</element-citation>
</ref>
<ref id="B99-genes-10-01050">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filatova</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Vasilyeva</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Marakhonov</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Voskresenskaya</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Zinchenko</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Skoblov</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Functional reassessment of PAX6 single nucleotide variants by in vitro splicing assay</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2019</year>
<volume>27</volume>
<fpage>488</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="doi">10.1038/s41431-018-0288-y</pub-id>
<pub-id pub-id-type="pmid">30315214</pub-id>
</element-citation>
</ref>
<ref id="B100-genes-10-01050">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishina</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ogata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hosono</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hotta</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Genotype-phenotype correlation of PAX6 gene mutations in aniridia</article-title>
<source/>Hum. Genome Var.
          <year>2016</year>
<volume>3</volume>
<fpage>15052</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2015.52</pub-id>
<pub-id pub-id-type="pmid">27081561</pub-id>
</element-citation>
</ref>
<ref id="B101-genes-10-01050">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crolla</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia</article-title>
<source/>Am. J. Hum. Genet.
          <year>2002</year>
<volume>71</volume>
<fpage>1138</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.1086/344396</pub-id>
<pub-id pub-id-type="pmid">12386836</pub-id>
</element-citation>
</ref>
<ref id="B102-genes-10-01050">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>FitzPatrick</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>The genetic architecture of aniridia and Gillespie syndrome</article-title>
<source/>Hum. Genet.
          <year>2019</year>
<volume>138</volume>
<fpage>881</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-018-1934-8</pub-id>
<pub-id pub-id-type="pmid">30242502</pub-id>
</element-citation>
</ref>
<ref id="B103-genes-10-01050">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jepeal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Favor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects</article-title>
<source/>Nat. Genet.
          <year>1994</year>
<volume>7</volume>
<fpage>463</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.1038/ng0894-463</pub-id>
<pub-id pub-id-type="pmid">7951315</pub-id>
</element-citation>
</ref>
<ref id="B104-genes-10-01050">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt-Sidor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Szymanska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Roszkowski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wierzba-Bobrowicz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zaremba</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Malformations of the brain in two fetuses with a compound heterozygosity for two PAX6 mutations</article-title>
<source/>Folia Neuropathol.
          <year>2009</year>
<volume>47</volume>
<fpage>372</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">20054790</pub-id>
</element-citation>
</ref>
<ref id="B105-genes-10-01050">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solomon</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Pineda-Alvarez</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Balog</surname>
<given-names>J.Z.</given-names>
</name>
<name>
<surname>Hadley</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gropman</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Nandagopal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Blain</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia</article-title>
<source/>Am. J. Med. Genet. Part A
          <year>2009</year>
<volume>149</volume>
<fpage>2543</fpage>
<lpage>2546</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33081</pub-id>
</element-citation>
</ref>
<ref id="B106-genes-10-01050">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Colby</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>A review of the clinical and genetic aspects of aniridia</article-title>
<source/>Semin. Ophthalmol.
          <year>2013</year>
<volume>28</volume>
<fpage>306</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.3109/08820538.2013.825293</pub-id>
<pub-id pub-id-type="pmid">24138039</pub-id>
</element-citation>
</ref>
<ref id="B107-genes-10-01050">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Truong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wierenga</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Craigen</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>V.W.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>L.C.</given-names>
</name>
</person-group>
<article-title>Detection and Quantification of Mosaic Mutations in Disease Genes by Next-Generation Sequencing</article-title>
<source/>J. Mol. Diagn.
          <year>2016</year>
<volume>18</volume>
<fpage>446</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmoldx.2016.01.002</pub-id>
<pub-id pub-id-type="pmid">26944031</pub-id>
</element-citation>
</ref>
<ref id="B108-genes-10-01050">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nieto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pomares</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Panel-based whole exome sequencing identifies novel mutations in microphthalmia and anophthalmia patients showing complex Mendelian inheritance patterns</article-title>
<source/>Mol. Genet. Genom. Med.
          <year>2017</year>
<volume>5</volume>
<fpage>709</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.329</pub-id>
</element-citation>
</ref>
<ref id="B109-genes-10-01050">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Extension of the mutation spectrum of PAX6 from three Chinese congenital aniridia families and identification of male gonadal mosaicism</article-title>
<source/>Mol. Genet. Genom. Med.
          <year>2018</year>
<volume>6</volume>
<fpage>1053</fpage>
<lpage>1067</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.481</pub-id>
</element-citation>
</ref>
<ref id="B110-genes-10-01050">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarilonte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Galdos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blanco-Kelly</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Villaverde</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rey-Zamora</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rebolleda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Munoz-Negrete</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Tahsin-Swafiri</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parental Mosaicism in PAX6 Causes Intra-Familial Variability: Implications for Genetic Counseling of Congenital Aniridia and Microphthalmia</article-title>
<source/>Front. Genet.
          <year>2018</year>
<volume>9</volume>
<fpage>479</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2018.00479</pub-id>
<pub-id pub-id-type="pmid">30386378</pub-id>
</element-citation>
</ref>
<ref id="B111-genes-10-01050">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubey</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Mahalaxmi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vijayalakshmi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sundaresan</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia</article-title>
<source/>Mol. Vis.
          <year>2015</year>
<volume>21</volume>
<fpage>88</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">25678763</pub-id>
</element-citation>
</ref>
<ref id="B112-genes-10-01050">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gramer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gramer</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Glaucoma and frequency of ocular and general diseases in 30 patients with aniridia: A clinical study</article-title>
<source/>Eur. J. Ophthalmol.
          <year>2012</year>
<volume>22</volume>
<fpage>104</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.5301/EJO.2011.8318</pub-id>
<pub-id pub-id-type="pmid">22167549</pub-id>
</element-citation>
</ref>
<ref id="B113-genes-10-01050">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>PAX6 aniridia syndrome: Clinics, genetics, and therapeutics</article-title>
<source/>Curr. Opin. Ophthalmol.
          <year>2017</year>
<volume>28</volume>
<fpage>436</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1097/ICU.0000000000000405</pub-id>
<pub-id pub-id-type="pmid">28598868</pub-id>
</element-citation>
</ref>
<ref id="B114-genes-10-01050">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCulley</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dahr</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Aniridia and optic nerve hypoplasia</article-title>
<source/>Eye
          <year>2005</year>
<volume>19</volume>
<fpage>762</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1038/sj.eye.6701642</pub-id>
<pub-id pub-id-type="pmid">15359227</pub-id>
</element-citation>
</ref>
<ref id="B115-genes-10-01050">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedersen</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Landsend</surname>
<given-names>E.C.S.</given-names>
</name>
<name>
<surname>Gilson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Neitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baraas</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Color Vision in Aniridia</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2018</year>
<volume>59</volume>
<fpage>2142</fpage>
<lpage>2152</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.17-23047</pub-id>
<pub-id pub-id-type="pmid">29801149</pub-id>
</element-citation>
</ref>
<ref id="B116-genes-10-01050">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedersen</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Neitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gilson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Landsend</surname>
<given-names>E.C.S.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Baraas</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>The Cone Photoreceptor Mosaic in Aniridia: Within-Family Phenotype-Genotype Discordance</article-title>
<source/>Ophthalmol. Retin.
          <year>2019</year>
<volume>3</volume>
<fpage>523</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1016/j.oret.2019.01.020</pub-id>
</element-citation>
</ref>
<ref id="B117-genes-10-01050">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagali</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wowra</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fries</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Latta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moslemani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Wylegala</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kasmann-Kellner</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations</article-title>
<source/>Ocul. Surf.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.jtos.2019.11.002</pub-id>
</element-citation>
</ref>
<ref id="B118-genes-10-01050">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagali</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wowra</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fries</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Latta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moslemani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Utheim</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Wylegala</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kasmann-Kellner</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>PAX6 Mutational Status Determines Aniridia-Associated Keratopathy Phenotype</article-title>
<source/>Ophthalmology
          <year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2019.09.034</pub-id>
</element-citation>
</ref>
<ref id="B119-genes-10-01050">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jinda</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Limwongse</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Atchaneeyasakul</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Phadke</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Run-on mutation in the PAX6 gene and chorioretinal degeneration in autosomal dominant aniridia</article-title>
<source/>Mol. Vis.
          <year>2011</year>
<volume>17</volume>
<fpage>1305</fpage>
<lpage>1309</lpage>
<pub-id pub-id-type="pmid">21633710</pub-id>
</element-citation>
</ref>
<ref id="B120-genes-10-01050">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Footz</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Mirzayans</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2009</year>
<volume>50</volume>
<fpage>3573</fpage>
<lpage>3579</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.08-3032</pub-id>
<pub-id pub-id-type="pmid">19279310</pub-id>
</element-citation>
</ref>
<ref id="B121-genes-10-01050">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Sami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Caprioli</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Asymmetric phenotype of Axenfeld-Rieger anomaly and aniridia associated with a novel PITX2 mutation</article-title>
<source/>Mol. Vis.
          <year>2011</year>
<volume>17</volume>
<fpage>1231</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="pmid">21617748</pub-id>
</element-citation>
</ref>
<ref id="B122-genes-10-01050">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Genomics and anterior segment dysgenesis: A review</article-title>
<source/>Clin. Exp. Ophthalmol.
          <year>2014</year>
<volume>42</volume>
<fpage>13</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1111/ceo.12152</pub-id>
<pub-id pub-id-type="pmid">24433355</pub-id>
</element-citation>
</ref>
<ref id="B123-genes-10-01050">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>C.Y.</given-names>
</name>
</person-group>
<article-title>A mouse model of aniridia reveals the in vivo downstream targets of Pax6 driving iris and ciliary body development in the eye</article-title>
<source/>Biochim. Biophys. Acta Mol. Basis Dis.
          <year>2017</year>
<volume>1863</volume>
<fpage>60</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2016.10.018</pub-id>
<pub-id pub-id-type="pmid">27771509</pub-id>
</element-citation>
</ref>
<ref id="B124-genes-10-01050">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Lacal</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Sasman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Losordo</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Kume</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>2015</fpage>
<lpage>2020</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1109540109</pub-id>
<pub-id pub-id-type="pmid">22171010</pub-id>
</element-citation>
</ref>
<ref id="B125-genes-10-01050">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variants in TRIM44 Cause Aniridia by Impairing PAX6 Expression</article-title>
<source/>Hum. Mutat.
          <year>2015</year>
<volume>36</volume>
<fpage>1164</fpage>
<lpage>1167</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22907</pub-id>
<pub-id pub-id-type="pmid">26394807</pub-id>
</element-citation>
</ref>
<ref id="B126-genes-10-01050">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.R.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Levinn</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Menzie</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Jefferson-George</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Adler-Wailes</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Sanford</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Lacbawan</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>G.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor and obesity in the WAGR syndrome</article-title>
<source/>N. Engl. J. Med.
          <year>2008</year>
<volume>359</volume>
<fpage>918</fpage>
<lpage>927</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0801119</pub-id>
<pub-id pub-id-type="pmid">18753648</pub-id>
</element-citation>
</ref>
<ref id="B127-genes-10-01050">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischbach</surname>
<given-names>B.V.</given-names>
</name>
<name>
<surname>Trout</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luis</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Sika</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>WAGR syndrome: A clinical review of 54 cases</article-title>
<source/>Pediatrics
          <year>2005</year>
<volume>116</volume>
<fpage>984</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2004-0467</pub-id>
<pub-id pub-id-type="pmid">16199712</pub-id>
</element-citation>
</ref>
<ref id="B128-genes-10-01050">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinawi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maranda</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chinault</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zascavage</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>S.U.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>R.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity</article-title>
<source/>Am. J. Med. Genet. Part A
          <year>2011</year>
<volume>155</volume>
<fpage>1272</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33878</pub-id>
</element-citation>
</ref>
<ref id="B129-genes-10-01050">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harcourt</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Bullen</surname>
<given-names>D.V.R.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Tassoni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Sabin</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Maternal inheritance of BDNF deletion, with phenotype of obesity and developmental delay in mother and child</article-title>
<source/>Am. J. Med. Genet. Part A
          <year>2018</year>
<volume>176</volume>
<fpage>194</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.38539</pub-id>
<pub-id pub-id-type="pmid">29160031</pub-id>
</element-citation>
</ref>
<ref id="B130-genes-10-01050">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatmari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Brian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.Q.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Skaug</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Senman</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping autism risk loci using genetic linkage and chromosomal rearrangements</article-title>
<source/>Nat. Genet.
          <year>2007</year>
<volume>39</volume>
<fpage>319</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1038/ng1985</pub-id>
<pub-id pub-id-type="pmid">17322880</pub-id>
</element-citation>
</ref>
<ref id="B131-genes-10-01050">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sisodiya</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Free</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Shorvon</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans</article-title>
<source/>Nat. Genet.
          <year>2001</year>
<volume>28</volume>
<fpage>214</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1038/90042</pub-id>
<pub-id pub-id-type="pmid">11431688</pub-id>
</element-citation>
</ref>
<ref id="B132-genes-10-01050">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Couet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cessans</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bonneau</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Obesity: A new feature of WAGR (del 11p) syndrome</article-title>
<source/>Clin. Dysmorphol.
          <year>1994</year>
<volume>3</volume>
<fpage>255</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1097/00019605-199407000-00012</pub-id>
<pub-id pub-id-type="pmid">7526938</pub-id>
</element-citation>
</ref>
<ref id="B133-genes-10-01050">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gul</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ogur</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tunca</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ozcan</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14)</article-title>
<source/>Am. J. Med. Genet.
          <year>2002</year>
<volume>107</volume>
<fpage>70</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.10013</pub-id>
<pub-id pub-id-type="pmid">11807873</pub-id>
</element-citation>
</ref>
<ref id="B134-genes-10-01050">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Proudlock</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Pradeep</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Gottlob</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Autosomal-dominant nystagmus, foveal hypoplasia and presenile cataract associated with a novel PAX6 mutation</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2014</year>
<volume>22</volume>
<fpage>344</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2013.162</pub-id>
<pub-id pub-id-type="pmid">23942204</pub-id>
</element-citation>
</ref>
<ref id="B135-genes-10-01050">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Microphthalmia, late onset keratitis, and iris coloboma/aniridia in a family with a novel PAX6 mutation</article-title>
<source/>Ophthalmic Genet.
          <year>2012</year>
<volume>33</volume>
<fpage>119</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.3109/13816810.2011.642452</pub-id>
<pub-id pub-id-type="pmid">22171686</pub-id>
</element-citation>
</ref>
<ref id="B136-genes-10-01050">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dansault</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jaliffa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>de la Houssaye</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bigot</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Catin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tattu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chopin</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities</article-title>
<source/>Mol. Vis.
          <year>2007</year>
<volume>13</volume>
<fpage>511</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">17417613</pub-id>
</element-citation>
</ref>
<ref id="B137-genes-10-01050">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawase</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Honna</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>A case of atypical WAGR syndrome with anterior segment anomaly and microphthalmos</article-title>
<source/>Arch. Ophthalmol.
          <year>2001</year>
<volume>119</volume>
<fpage>1855</fpage>
<lpage>1856</lpage>
<pub-id pub-id-type="pmid">11735802</pub-id>
</element-citation>
</ref>
<ref id="B138-genes-10-01050">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamachi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Uchikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanouchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sekido</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development</article-title>
<source/>Genes Dev.
          <year>2001</year>
<volume>15</volume>
<fpage>1272</fpage>
<lpage>1286</lpage>
<pub-id pub-id-type="doi">10.1101/gad.887101</pub-id>
<pub-id pub-id-type="pmid">11358870</pub-id>
</element-citation>
</ref>
<ref id="B139-genes-10-01050">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberdam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Petit</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sangari</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aberdam</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<elocation-id>e0179913</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0179913</pub-id>
<pub-id pub-id-type="pmid">28640863</pub-id>
</element-citation>
</ref>
<ref id="B140-genes-10-01050">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Livesey</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>G.G.W.</given-names>
</name>
<name>
<surname>Bodek</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Calvas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA-protein interaction</article-title>
<source/>Genet. Med. Off. J. Am. Coll. Med. Genet.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41436-019-0685-9</pub-id>
</element-citation>
</ref>
<ref id="B141-genes-10-01050">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>A large novel deletion downstream of PAX6 gene in a Chinese family with ocular coloboma</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e83073</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0083073</pub-id>
<pub-id pub-id-type="pmid">24349436</pub-id>
</element-citation>
</ref>
<ref id="B142-genes-10-01050">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goolam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carstens</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bentley</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kingsbury</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tsogka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barlow</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>T.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial congenital cataract, coloboma, and nystagmus phenotype with variable expression caused by mutation in PAX6 in a South African family</article-title>
<source/>Mol. Vis.
          <year>2018</year>
<volume>24</volume>
<fpage>407</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">29930474</pub-id>
</element-citation>
</ref>
<ref id="B143-genes-10-01050">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory-Evans</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Halford</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Ocular coloboma: A reassessment in the age of molecular neuroscience</article-title>
<source/>J. Med. Genet.
          <year>2004</year>
<volume>41</volume>
<fpage>881</fpage>
<lpage>891</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.025494</pub-id>
<pub-id pub-id-type="pmid">15591273</pub-id>
</element-citation>
</ref>
<ref id="B144-genes-10-01050">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>U.K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>A family with a mild form of congenital nystagmus and optic disc coloboma caused by a novel PAX6 mutation</article-title>
<source/>Gene
          <year>2019</year>
<volume>705</volume>
<fpage>177</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2019.04.035</pub-id>
<pub-id pub-id-type="pmid">30986449</pub-id>
</element-citation>
</ref>
<ref id="B145-genes-10-01050">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cecconi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Andrejewski</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kammandel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gruss</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Spatial specification of mammalian eye territories by reciprocal transcriptional repression of Pax2 and Pax6</article-title>
<source/>Development
          <year>2000</year>
<volume>127</volume>
<fpage>4325</fpage>
<lpage>4334</lpage>
<pub-id pub-id-type="pmid">11003833</pub-id>
</element-citation>
</ref>
<ref id="B146-genes-10-01050">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerber</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alzayady</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Burglen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bremond-Gignac</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marchesin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Funalot</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Calmon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Durr</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2016</year>
<volume>98</volume>
<fpage>971</fpage>
<lpage>980</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.004</pub-id>
<pub-id pub-id-type="pmid">27108797</pub-id>
</element-citation>
</ref>
<ref id="B147-genes-10-01050">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McEntagart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Rainger</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seawright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Baere</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Verdin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bergendahl</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rainger</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Restricted Repertoire of De Novo Mutations in ITPR1 Cause Gillespie Syndrome with Evidence for Dominant-Negative Effect</article-title>
<source/>Am. J. Hum. Genet.
          <year>2016</year>
<volume>98</volume>
<fpage>981</fpage>
<lpage>992</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.018</pub-id>
<pub-id pub-id-type="pmid">27108798</pub-id>
</element-citation>
</ref>
<ref id="B148-genes-10-01050">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ticho</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Hilchie-Schmidt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Egel</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Traboulsi</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Ocular findings in Gillespie-like syndrome: Association with a new PAX6 mutation</article-title>
<source/>Ophthalmic Genet.
          <year>2006</year>
<volume>27</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1080/13816810600976897</pub-id>
<pub-id pub-id-type="pmid">17148041</pub-id>
</element-citation>
</ref>
<ref id="B149-genes-10-01050">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Punnett</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters’ anomaly</article-title>
<source/>Nat. Genet.
          <year>1994</year>
<volume>6</volume>
<fpage>168</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1038/ng0294-168</pub-id>
<pub-id pub-id-type="pmid">8162071</pub-id>
</element-citation>
</ref>
<ref id="B150-genes-10-01050">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Winterpacht</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Drechsler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Royer-Pokora</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Blankenagel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zabel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wildhardt</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Ten novel mutations found in Aniridia</article-title>
<source/>Hum. Mutat.
          <year>1998</year>
<volume>12</volume>
<fpage>304</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-1004(1998)12:5&lt;304::AID-HUMU3&gt;3.0.CO;2-D</pub-id>
<pub-id pub-id-type="pmid">9792406</pub-id>
</element-citation>
</ref>
<ref id="B151-genes-10-01050">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McGreal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cohen-Tayar</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rockowitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wilczek</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ashery-Padan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shechter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers</article-title>
<source/>Epigenet. Chromatin
          <year>2016</year>
<volume>9</volume>
<fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/s13072-016-0087-z</pub-id>
</element-citation>
</ref>
<ref id="B152-genes-10-01050">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rockowitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ashery-Padan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Identification of in vivo DNA-binding mechanisms of Pax6 and reconstruction of Pax6-dependent gene regulatory networks during forebrain and lens development</article-title>
<source/>Nucleic Acids Res.
          <year>2015</year>
<volume>43</volume>
<fpage>6827</fpage>
<lpage>6846</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv589</pub-id>
<pub-id pub-id-type="pmid">26138486</pub-id>
</element-citation>
</ref>
<ref id="B153-genes-10-01050">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsui</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>CTCF-Mediated and Pax6-Associated Gene Expression in Corneal Epithelial Cell-Specific Differentiation</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0162071</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0162071</pub-id>
<pub-id pub-id-type="pmid">27583466</pub-id>
</element-citation>
</ref>
<ref id="B154-genes-10-01050">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Mapping the Pax6 3′ untranslated region microRNA regulatory landscape</article-title>
<source/>BMC Genom.
          <year>2018</year>
<volume>19</volume>
<elocation-id>820</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12864-018-5212-x</pub-id>
<pub-id pub-id-type="pmid">30442116</pub-id>
</element-citation>
</ref>
<ref id="B155-genes-10-01050">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhinge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Poschmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Namboori</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jia Hui Loh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Traczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prabhakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>L.W.</given-names>
</name>
</person-group>
<article-title>MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-beta/BMP signaling</article-title>
<source/>EMBO J.
          <year>2014</year>
<volume>33</volume>
<fpage>1271</fpage>
<lpage>1283</lpage>
<pub-id pub-id-type="doi">10.1002/embj.201387215</pub-id>
<pub-id pub-id-type="pmid">24802670</pub-id>
</element-citation>
</ref>
<ref id="B156-genes-10-01050">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaham</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gueta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mor</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Oren-Giladi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shomron</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Keydar-Prizant</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pax6 regulates gene expression in the vertebrate lens through miR-204</article-title>
<source/>PLoS Genet.
          <year>2013</year>
<volume>9</volume>
<elocation-id>e1003357</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003357</pub-id>
<pub-id pub-id-type="pmid">23516376</pub-id>
</element-citation>
</ref>
<ref id="B157-genes-10-01050">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalom-Feuerstein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Serror</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De La Forest Divonne</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Petit</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aberdam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Damour</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vigouroux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gaggioli</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pluripotent stem cell model reveals essential roles for miR-450b-5p and miR-184 in embryonic corneal lineage specification</article-title>
<source/>Stem Cells
          <year>2012</year>
<volume>30</volume>
<fpage>898</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1068</pub-id>
<pub-id pub-id-type="pmid">22367714</pub-id>
</element-citation>
</ref>
<ref id="B158-genes-10-01050">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdasco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Catala-Mora</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zanon-Moreno</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>11762</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-12084-1</pub-id>
<pub-id pub-id-type="pmid">28924151</pub-id>
</element-citation>
</ref>
<ref id="B159-genes-10-01050">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Arnes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guney</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Burnum-Johnson</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Rabadan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ansong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Orr</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Long Noncoding RNA Paupar Modulates PAX6 Regulatory Activities to Promote Alpha Cell Development and Function</article-title>
<source/>Cell Metab.
          <year>2019</year>
<volume>30</volume>
<fpage>1091</fpage>
<lpage>1106.e8</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2019.09.013</pub-id>
<pub-id pub-id-type="pmid">31607563</pub-id>
</element-citation>
</ref>
<ref id="B160-genes-10-01050">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sasamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Katori</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ichikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sekiguchi</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Co-ordinated ocular development from human iPS cells and recovery of corneal function</article-title>
<source/>Nature
          <year>2016</year>
<volume>531</volume>
<fpage>376</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1038/nature17000</pub-id>
<pub-id pub-id-type="pmid">26958835</pub-id>
</element-citation>
</ref>
<ref id="B161-genes-10-01050">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Efficient generation of lens progenitor cells from cataract patient-specific induced pluripotent stem cells</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e32612</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0032612</pub-id>
<pub-id pub-id-type="pmid">22403680</pub-id>
</element-citation>
</ref>
<ref id="B162-genes-10-01050">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Wahlin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Birk</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Zack</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Chakravarti</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cornea organoids from human induced pluripotent stem cells</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>41286</fpage>
<pub-id pub-id-type="doi">10.1038/srep41286</pub-id>
<pub-id pub-id-type="pmid">28128337</pub-id>
</element-citation>
</ref>
<ref id="B163-genes-10-01050">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muguruma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sekiguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yonemura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eiraku</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sasai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Self-formation of optic cups and storable stratified neural retina from human ESCs</article-title>
<source/>Cell Stem Cell
          <year>2012</year>
<volume>10</volume>
<fpage>771</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.05.009</pub-id>
<pub-id pub-id-type="pmid">22704518</pub-id>
</element-citation>
</ref>
<ref id="B164-genes-10-01050">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gamm</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Capowski</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The Role of FGF9 In The Production of Neural Retina And RPE In A Pluripotent Stem Cell Model of Early Human Retinal Development</article-title>
<source/>Am. J. Ophthalmol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.ajo.2019.04.033</pub-id>
<pub-id pub-id-type="pmid">31078532</pub-id>
</element-citation>
</ref>
<ref id="B165-genes-10-01050">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parfitt</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Munro</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Jovanovic</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kanuga</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Muthiah</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>18</volume>
<fpage>769</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.03.021</pub-id>
<pub-id pub-id-type="pmid">27151457</pub-id>
</element-citation>
</ref>
<ref id="B166-genes-10-01050">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blau</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>G.Q.</given-names>
</name>
</person-group>
<article-title>Stem Cells in the Treatment of Disease</article-title>
<source/>N. Engl. J. Med.
          <year>2019</year>
<volume>380</volume>
<fpage>1748</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra1716145</pub-id>
<pub-id pub-id-type="pmid">31042827</pub-id>
</element-citation>
</ref>
<ref id="B167-genes-10-01050">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>X.X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients</article-title>
<source/>Stem Cell Rep.
          <year>2018</year>
<volume>10</volume>
<fpage>1267</fpage>
<lpage>1281</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.02.003</pub-id>
</element-citation>
</ref>
<ref id="B168-genes-10-01050">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Smart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tracey-White</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Moosajee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mechanism and evidence of nonsense suppression therapy for genetic eye disorders</article-title>
<source/>Exp. Eye Res.
          <year>2017</year>
<volume>155</volume>
<fpage>24</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.exer.2017.01.001</pub-id>
<pub-id pub-id-type="pmid">28065590</pub-id>
</element-citation>
</ref>
<ref id="B169-genes-10-01050">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wasan</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Sivak</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>C.Y.</given-names>
</name>
</person-group>
<article-title>Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia</article-title>
<source/>Mol. Ther. Nucleic Acids
          <year>2017</year>
<volume>7</volume>
<fpage>417</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtn.2017.05.002</pub-id>
<pub-id pub-id-type="pmid">28624217</pub-id>
</element-citation>
</ref>
<ref id="B170-genes-10-01050">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory-Evans</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wasan</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Metcalfe</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Gregory-Evans</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects</article-title>
<source/>J. Clin. Investig.
          <year>2014</year>
<volume>124</volume>
<fpage>111</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1172/JCI70462</pub-id>
<pub-id pub-id-type="pmid">24355924</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="genes-10-01050-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Human <italic>PAX6</italic> locus. (<bold>A</bold>) <italic>PAX6</italic> gene structure in 11p13, with 14 exons (boxes, colours represent respective protein domains), promoters P0, P1 and Pα (boxes with diagonal lines) and regulatory elements (oval shapes with horizontal lines) including ectodermal enhancer (EE), located upstream <italic>PAX6</italic>, and Downstream Regulatory Region (DRR) and SIMO, within the introns of neighbour gene <italic>ELP4</italic> (last four exons represented by orange boxes). EE: ectodermal enhancer; DRR: downstream regulatory region. (<bold>B</bold>) Main PAX6 isoforms, canonical PAX6 and PAX6(5a) and their respective structure with functional domains. PD: paired domain; NTS: N-terminal subdomain; CTS: C-terminal subdomain; LNK: linker region; HD: homeodomain; PST: proline-serine-threonine domain; aa: amino acids.</p>
</caption>
<graphic xlink:href="genes-10-01050-g001"></graphic>
</fig>
<fig id="genes-10-01050-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Schematic representation of previously reported deletions in 11p13 encompassing regulatory regions 3’ of <italic>PAX6</italic>. Genes are represented by grey boxes and arrows indicate direction of transcription. <italic>PAX6</italic> is highlighted in black. Known <italic>PAX6</italic> enhancers are indicated by oval shapes with horizontal lines with focus on SIMO and E180B. Coloured bars represent deletions identified in different cohorts of aniridia patients without <italic>PAX6</italic> mutations [<xref ref-type="bibr" rid="B68-genes-10-01050">68</xref>,<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>,<xref ref-type="bibr" rid="B73-genes-10-01050">73</xref>,<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>,<xref ref-type="bibr" rid="B76-genes-10-01050">76</xref>,<xref ref-type="bibr" rid="B77-genes-10-01050">77</xref>]. The vertical dashed lines indicate a common region deleted in all mentioned aniridia patients, which was defined first as 245 Kb long by Ansari et al. (blue dashed lines) and later reduced to 18 Kb by Plaisancie et al. (red dashed lines) [<xref ref-type="bibr" rid="B72-genes-10-01050">72</xref>,<xref ref-type="bibr" rid="B75-genes-10-01050">75</xref>]. Genomic coordinates are based on human genome assembly hg19.</p>
</caption>
<graphic xlink:href="genes-10-01050-g002"></graphic>
</fig>
<fig id="genes-10-01050-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Distribution of different mutation types in the <italic>PAX6</italic> Mutation Database. (<bold>A</bold>) All of the mutations reported in the database. (<bold>B</bold>) Mutation frequencies associated to aniridia. (<bold>C</bold>) <italic>PAX6</italic> mutation distribution in non-aniridia phenotypes. PTC (premature termination codon) include all mutations predicted to cause a premature stop codon and include nonsense, frameshift and splice site variants. CTE refer to variants that cause C-terminal extension of PAX6.</p>
</caption>
<graphic xlink:href="genes-10-01050-g003"></graphic>
</fig>
<fig id="genes-10-01050-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Phenotypic spectrum of patients with <italic>PAX6</italic> mutations. (<bold>A</bold>) Classical aniridia phenotype showing complete iris hypoplasia with central corneal opacity and vascularisation, (<bold>B</bold>) fundus imaging indicating absence of foveal reflex and (<bold>C</bold>) optical coherence tomography (OCT) of the macula showing foveal hypoplasia. (<bold>D</bold>) Left eye of a patient diagnosed with bilateral microphthalmia with microcornea. (<bold>E</bold>) Patient diagnosed with dominant nystagmus with no iris abnormalities and (<bold>F</bold>) foveal hypoplasia on OCT.</p>
</caption>
<graphic xlink:href="genes-10-01050-g004"></graphic>
</fig>
<fig id="genes-10-01050-f005" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p>Spectrum of coding <italic>PAX6</italic> mutations causing non-aniridia phenotypes. A representation of canonical PAX6 structure is shown with respective domains and amino acid distribution. Mutations and respective phenotypes were collected from the <italic>PAX6</italic> Mutation Database and the Human Genome Mutation Database (HGMD). The majority of mutations are included in the paired domain (NTS and CTS) and constitute missense mutations (squares). Mutations in alternative exon 5a are shown in blue. <sup>a</sup> Isolated foveal hypoplasia and nystagmus without iris abnormalities; variants shown in grey show cases presenting full iris but with possible mild structural defects [<xref ref-type="bibr" rid="B86-genes-10-01050">86</xref>]; <sup>b</sup> Optic nerve malformations include optic nerve coloboma, aplasia, and morning glory disc; NTS: N-terminal subdomain; CTS: C-terminal subdomain; LNK: linker region; HD: homeodomain; PSTD: proline-serine-threonine domain; aa: amino acids; ASD: anterior segment dysgenesis.</p>
</caption>
<graphic xlink:href="genes-10-01050-g005"></graphic>
</fig>
<table-wrap id="genes-10-01050-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">genes-10-01050-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Summary of conserved regulatory elements in the <italic>PAX6</italic> locus and their regulation of <italic>PAX6</italic> ocular and extra-ocular expression.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Regulatory Element</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Distance to <italic>PAX6</italic> (Kb)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Location</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Eye Expression</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Extra-Ocular Expression</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RB</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−215</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diencephalon, telencephalon, pineal gland</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B37-genes-10-01050">37</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E180B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−176</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RGCs and optic nerve</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Trigeminal ganglia, dorsal spinal cord neurons</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS8B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−177</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS8A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−176</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−172</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural structures</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B57-genes-10-01050">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−168</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Optic cup and neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diencephalon</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B57-genes-10-01050">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−162</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HS2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−161</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SIMO</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−153</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lens and neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diencephalon, hindbrain, neural tube</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B25-genes-10-01050">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E120</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−126</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Olfactory bulbs, brain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E100</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−104</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Diencephalon, olfactory region</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B58-genes-10-01050">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E60A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−54</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>ELP4</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Optic cup and neural retina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural structures</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B57-genes-10-01050">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7CE1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−18</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>PAX6</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Late eye development</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B59-genes-10-01050">59</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NRE</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−13</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Intron <italic>PAX6</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neural retina, ciliary body, iris</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B54-genes-10-01050">54</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0CE1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5’UTR <italic>PAX6</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B26-genes-10-01050">26</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE14 (P2)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pancreas</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">EE</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cornea, lens, conjunctiva and lacrimal gland</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B54-genes-10-01050">54</xref>,<xref ref-type="bibr" rid="B60-genes-10-01050">60</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE12 (P)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pancreatic islets</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE11</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pineal gland</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE10 (Up-9)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">9</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No specific pattern</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE9 (Up-10)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">12</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pineal gland</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse-like Paupar</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">54</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B61-genes-10-01050">61</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PE3 (E-52)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">57</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developing pancreas and brain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B62-genes-10-01050">62</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E-55/C</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">59</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No specific pattern</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E-55/B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">60</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No specific pattern</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E-55/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">70</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hindbrain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E-72</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">71</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No specific pattern</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PE4 (E120)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">110</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developing pancreas, olfactory tract, cerebellum, hindbrain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B62-genes-10-01050">62</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE5 (Id855)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">178</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Forebrain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">186</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hindbrain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">214</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Olfactory bulbs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E200</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">214</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Olfactory bulbs, cerebellum</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B63-genes-10-01050">63</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">agCNE1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">224</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Trigeminal ganglia, dorsal spinal cord neurons</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">E250</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">247</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No specific pattern</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B56-genes-10-01050">56</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>